Lessening of porcine epidemic diarrhoea virus susceptibility in piglets after editing of the CMP-N-glycolylneuraminic acid hydroxylase gene with CRISPR/Cas9 to nullify N-glycolylneuraminic acid expression

✅ 全文

利用CRISPR/Cas9编辑CMP-N-羟乙酰神经氨酸羟化酶基因以消除N-羟乙酰神经氨酸表达后降低仔猪对猪流行性腹泻病毒的易感性

作者 Ching‐Fu Tu; Chin-Kai Chuang; Kai-Hsuan Hsiao; Chien-Hong Chen; Chi‐Min Chen; Su-Hei Peng; Yu-Hsiu Su; Ming‐Tang Chiou; Chon‐Ho Yen; Shao‐Wen Hung; Tien‐Shuh Yang; Chuan‐Mu Chen 期刊 PLoS ONE 发表日期 2019 ISSN 1932-6203 DOI 10.1371/journal.pone.0217236 类型 原创研究 (Original Research)

📄 英文摘要 English Abstract

EN

The porcine epidemic diarrhoea virus (PEDV) devastates the health of piglets but may not infect piglets whose CMP-N-glycolylneuraminic acid hydroxylase (CMAH) gene is mutated (knockouts, KO) by using CRISPR/Cas9 gene editing techniques. This hypothesis was tested by using KO piglets that were challenged with PEDV. Two single-guide RNAs targeting the CMAH gene and Cas9 mRNA were microinjected into the cytoplasm of newly fertilized eggs. Four live founders generated and proven to be biallelic KO, lacking detectable N-glycolylneuraminic acid (NGNA). The founders were bred, and homozygous offspring were obtained. Two-day-old (in exps. I, n = 6, and III, n = 15) and 3-day-old (in exp. II, n = 9) KO and wild-type (WT, same ages in respective exps.) piglets were inoculated with TCID50 1x103 PEDV and then fed 20 mL of infant formula (in exps. I and II) or sow's colostrum (in exp. III) every 4 hours. In exp. III, the colostrum was offered 6 times and was then replaced with Ringer/5% glucose solution. At 72 hours post-PEDV inoculation (hpi), the animals either deceased or euthanized were necropsied and intestines were sampled. In all 3 experiments, the piglets showed apparent outward clinical manifestations suggesting that infection occurred despite the CMAH KO. In exp. I, all 6 WT piglets and only 1 of 6 KO piglets died at 72 hpi. Histopathology and immunofluorescence staining showed that the villus epithelial cells of WT piglets were severely exfoliated, but only moderate exfoliation and enterocyte vacuolization was observed in KO piglets. In exp. II, delayed clinical symptoms appeared, yet the immunofluorescence staining/histopathologic inspection (I/H) scores of the two groups differed little. In exp. III, the animals exhibited clinical and pathological signs after inoculation similar to those in exp. II. These results suggest that porcine CMAH KO with nullified NGNA expression are not immune to PEDV but that this KO may lessen the severity of the infection and delay its occurrence.

📄 中文摘要 Chinese Abstract

中文
猪流行性腹泻(PED)于1971年由英国兽医Oldham首次确认为一种肠道疾病[1];随后,PED病毒(PEDV)由比利时根特大学的Pensaert和de Bouck分离得到[2]。此后,PEDV相关腹泻在欧洲被广泛检测到。在亚洲,该病于1982年被报道[3],此后对亚洲养猪业造成了巨大影响。PEDV基因组由一条约28 kb的正链单链RNA组成,包含7个开放阅读框(ORF),包括ORF1a、ORF1b和ORF2-6[9]。PEDV感染途径主要通过S蛋白介导。PEDV首先与宿主肠道中的唾液酸(神经氨酸,NA)接触[12],然后通过结合上皮细胞上的氨基肽酶N(APN)感染小肠绒毛[13, 14]。猪流行性腹泻病毒(PEDV)严重危害仔猪健康,但可能无法感染通过CRISPR/Cas9基因编辑技术使其CMP-N-羟乙酰神经氨酸羟化酶(CMAH)基因发生突变(敲除,KO)的仔猪。

📋 英文结构化总结 English Structured Summary

全文整理

EN

Background:

Porcine epidemic diarrhoea (PED) was first recognized as an enteric disease in 1971 by the British veterinarian Oldham [1]; subsequently, the PED virus (PEDV) was isolated by Pensaert and de Bouck [2] at Ghent University in Belgium. Since then, PEDV-associated diarrhoea has been widely detected in Europe. In Asia, it was reported in 1982 [3], and it has subsequently greatly impacted the Asian pork industry. The PEDV genome consists of a positive single-stranded RNA approximately 28 kb in length that contains 7 open reading frames (ORF), including ORF1a, ORF1b, and ORF2-6 [9]. The pathway of PEDV infection occurs mainly through the S-protein. PEDV first contacts sialic acids (neuraminic acid, NA) in host intestine [12] and then infects the villi by binding to aminopeptidase N (APN) on epithelial cells [13, 14]. The porcine epidemic diarrhoea virus (PEDV) devastates the health of piglets but may not infect piglets whose CMP-N-glycolylneuraminic acid hydroxylase (CMAH) gene is mutated (knockouts, KO) by using CRISPR/Cas9 gene editing techniques.

Methods:

Two single-guide RNAs targeting the CMAH gene and Cas9 mRNA were microinjected into the cytoplasm of newly fertilized eggs. Four live founders generated and proven to be biallelic KO, lacking detectable N-glycolylneuraminic acid (NGNA). The founders were bred, and homozygous offspring were obtained. Two-day-old (in exps. I, n = 6, and III, n = 15) and 3-day-old (in exp. II, n = 9) KO and wild-type (WT, same ages in respective exps.) piglets were inoculated with TCID50 1x103 PEDV and then fed 20 mL of infant formula (in exps. I and II) or sow’s colostrum (in exp. III) every 4 hours. In exp. III, the colostrum was offered 6 times and was then replaced with Ringer/5% glucose solution. At 72 hours post-PEDV inoculation (hpi), the animals either deceased or euthanized were necropsied and intestines were sampled.

Results:

In all 3 experiments, the piglets showed apparent outward clinical manifestations suggesting that infection occurred despite the CMAH KO. In exp. I, all 6 WT piglets and only 1 of 6 KO piglets died at 72 hpi. Histopathology and immunofluorescence staining showed that the villus epithelial cells of WT piglets were severely exfoliated, but only moderate exfoliation and enterocyte vacuolization was observed in KO piglets. In exp. II, delayed clinical symptoms appeared, yet the immunofluorescence staining/histopathologic inspection (I/H) scores of the two groups differed little. In exp. III, the animals exhibited clinical and pathological signs after inoculation similar to those in exp. II.

Data Summary:

In exp. I, all 6 WT piglets and only 1 of 6 KO piglets died at 72 hpi. In exp. II, the I/H scores of the two groups differed little. In exp. III, the animals exhibited clinical and pathological signs after inoculation similar to those in exp. II.

Conclusions:

These results suggest that porcine CMAH KO with nullified NGNA expression are not immune to PEDV but that this KO may lessen the severity of the infection and delay its occurrence.

Practical Significance:

The PEDV-associated diarrhoea has greatly impacted the Asian pork industry; in China during 2010 and 2011, over one million nursing piglets were lost due to PEDV-associated diarrhoea [4]; in 2013, PEDV emerged in Korea and the USA [5–7] as well as in Taiwan [8], causing great economic losses. The lessening of PEDV susceptibility in piglets after editing of the CMAH gene with CRISPR/Cas9 offers a potential real-world application to reduce piglet mortality and economic losses in the pork industry.

📋 中文结构化总结 Chinese Structured Summary

中文

背景:

猪流行性腹泻(PED)于1971年由英国兽医Oldham首次确认为一种肠道疾病[1];随后,PED病毒(PEDV)由比利时根特大学的Pensaert和de Bouck分离得到[2]。此后,PEDV相关腹泻在欧洲被广泛检测到。在亚洲,该病于1982年被报道[3],此后对亚洲养猪业造成了巨大影响。PEDV基因组由一条约28 kb的正链单链RNA组成,包含7个开放阅读框(ORF),包括ORF1a、ORF1b和ORF2-6[9]。PEDV感染途径主要通过S蛋白介导。PEDV首先与宿主肠道中的唾液酸(神经氨酸,NA)接触[12],然后通过结合上皮细胞上的氨基肽酶N(APN)感染小肠绒毛[13, 14]。猪流行性腹泻病毒(PEDV)严重危害仔猪健康,但可能无法感染通过CRISPR/Cas9基因编辑技术使其CMP-N-羟乙酰神经氨酸羟化酶(CMAH)基因发生突变(敲除,KO)的仔猪。

方法:

将靶向CMAH基因的两条单导RNA和Cas9 mRNA显微注射入新受精卵的细胞质中。获得4只活体创始猪,经证实为双等位基因KO,缺乏可检测的N-羟乙酰神经氨酸(NGNA)。对创始猪进行繁育,获得纯合子后代。2日龄(实验I,n = 6;实验III,n = 15)和3日龄(实验II,n = 9)的KO和野生型(WT,各实验中同龄)仔猪接种TCID50为1×10³的PEDV,随后每4小时饲喂20 mL婴儿配方奶(实验I和II)或母猪初乳(实验III)。在实验III中,初乳饲喂6次后替换为林格氏液/5%葡萄糖溶液。在PEDV接种后72小时(hpi),对死亡或安乐死的动物进行尸检并采集肠道样本。

结果:

在所有3个实验中,仔猪均表现出明显的外部临床症状,提示尽管CMAH基因被敲除,感染仍然发生。在实验I中,所有6只WT仔猪和6只KO仔猪中的1只在72 hpi时死亡。组织病理学和免疫荧光染色显示,WT仔猪的绒毛上皮细胞严重脱落,而KO仔猪仅观察到中度脱落和肠细胞空泡化。在实验II中,临床症状出现延迟,但两组的免疫荧光染色/组织病理学检查(I/H)评分差异不大。在实验III中,动物接种后表现出与实验II相似的临床和病理体征。

数据总结:

在实验I中,所有6只WT仔猪和6只KO仔猪中的1只在72 hpi时死亡。在实验II中,两组的I/H评分差异不大。在实验III中,动物接种后表现出与实验II相似的临床和病理体征。

结论:

这些结果表明,CMAH基因敲除且NGNA表达缺失的猪对PEDV并非免疫,但这种敲除可能减轻感染的严重程度并延迟其发生。

实际意义:

PEDV相关腹泻对亚洲养猪业造成了巨大影响;2010年至2011年间,中国因PEDV相关腹泻损失了超过一百万头哺乳仔猪[4];2013年,PEDV在韩国和美国[5-7]以及中国台湾[8]暴发,造成了巨大的经济损失。通过CRISPR/Cas9编辑CMAH基因降低仔猪对PEDV的易感性,为减少养猪业中仔猪死亡率和经济损失提供了潜在的实际应用价值。

📖 英文全文 English Full Text

EN

RESEARCH ARTICLE Lessening of porcine epidemic diarrhoea virus susceptibility in piglets after editing of the

CMP-N-glycolylneuraminic acid hydroxylase gene with CRISPR/Cas9 to nullify N- glycolylneuraminic acid expression

Ching-Fu TuID1*, Chin-kai Chuang1☯, Kai-Hsuan Hsiao1,2☯, Chien-Hong Chen1☯¤a, Chi- Min Chen3¤b, Su-Hei Peng1, Yu-Hsiu Su1, Ming-Tang Chiou4, Chon-Ho Yen1, Shao- Wen Hung5, Tien-Shuh Yang1,6, Chuan-Mu Chen2,7

1 Division of Animal Technology, Animal Technology Laboratories, Agricultural Technology Research

Institute, Xiangshan Dist., Hsinchu, Taiwan, R.O.C, 2 Department of Life Sciences, National Chung Hsing

University, South Dist., Taichung, Taiwan, R.O.C, 3 Division of Animal Medicine, Animal Technology

Laboratories, Agricultural Technology Research Institute, Xiangshan Dist., Hsinchu, Taiwan, R.O.C,

4 Department of Veterinary Medicine, College of Veterinary Medicine, National of Science and Technology,

Pingtung, Taiwan, ROC, 5 Division of Animal Industry, Animal Technology Laboratories, Agricultural

Technology Research Institute, Xiangshan Dist., Hsinchu, Taiwan, R.O.C, 6 Department of Biotechnology and Animal Science, National Ilan University, Yilan, Yilan, Taiwan, R.O.C, 7 The iEGG and Animal

Biotechnology Center, National Chung Hsinh University, Taichung, Taiwan, R.O.C

☯These authors contributed equally to this work.

¤a Current address: Reproductive Medicine Center, Lee Women’s Hospital, Taichung, Taiwan, R.O.C.

¤b Current address: Chao Kun Biotech Ltd., Taipei, Taiwan, R.O.C.

* cftu@mail.atri.org.tw Abstract The porcine epidemic diarrhoea virus (PEDV) devastates the health of piglets but may not infect piglets whose CMP-N-glycolylneuraminic acid hydroxylase (CMAH) gene is mutated (knockouts, KO) by using CRISPR/Cas9 gene editing techniques. This hypothesis was tested by using KO piglets that were challenged with PEDV. Two single-guide RNAs target- ing the CMAH gene and Cas9 mRNA were microinjected into the cytoplasm of newly fertil- ized eggs. Four live founders generated and proven to be biallelic KO, lacking detectable N- glycolylneuraminic acid (NGNA). The founders were bred, and homozygous offspring were obtained. Two-day-old (in exps. I, n = 6, and III, n = 15) and 3-day-old (in exp. II, n = 9) KO and wild-type (WT, same ages in respective exps.) piglets were inoculated with TCID50

1x103 PEDV and then fed 20 mL of infant formula (in exps. I and II) or sow’s colostrum (in exp. III) every 4 hours. In exp. III, the colostrum was offered 6 times and was then replaced with Ringer/5% glucose solution. At 72 hours post-PEDV inoculation (hpi), the animals either deceased or euthanized were necropsied and intestines were sampled. In all 3 experi- ments, the piglets showed apparent outward clinical manifestations suggesting that infection occurred despite the CMAH KO. In exp. I, all 6 WT piglets and only 1 of 6 KO piglets died at

72 hpi. Histopathology and immunofluorescence staining showed that the villus epithelial cells of WT piglets were severely exfoliated, but only moderate exfoliation and enterocyte

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 1 / 25 a1111111111 a1111111111 a1111111111 a1111111111 a1111111111

OPEN ACCESS Citation: Tu C-F, Chuang C-k, Hsiao K-H, Chen C- H, Chen C-M, Peng S-H, et al. (2019) Lessening of porcine epidemic diarrhoea virus susceptibility in piglets after editing of the CMP-N- glycolylneuraminic acid hydroxylase gene with

CRISPR/Cas9 to nullify N-glycolylneuraminic acid expression. PLoS ONE 14(5): e0217236. https:// doi.org/10.1371/journal.pone.0217236

Editor: Xiuchun Tian, University of Connecticut, UNITED STATES

Received: January 29, 2019 Accepted: May 7, 2019 Published: May 29, 2019

Copyright: © 2019 Tu et al. This is an open access article distributed under the terms of the Creative

Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability Statement: All relevant data are within the manuscript and its Supporting

Information files.

Funding: The financial assistances (MOST 104- 2321-B-866-001, MOST 105-2321-B-886-002 and

MOST 106-2321-B-866-002, all to CFT) were provided by the Ministry of Science and

Technology, Executive Yuan, Taiwan, ROC to support the research and salaries for the author of vacuolization was observed in KO piglets. In exp. II, delayed clinical symptoms appeared, yet the immunofluorescence staining/histopathologic inspection (I/H) scores of the two groups differed little. In exp. III, the animals exhibited clinical and pathological signs after inoculation similar to those in exp. II. These results suggest that porcine CMAH KO with nul- lified NGNA expression are not immune to PEDV but that this KO may lessen the severity of the infection and delay its occurrence.

Introduction Porcine epidemic diarrhoea (PED) was first recognized as an enteric disease in 1971 by the

British veterinarian Oldham [1]; subsequently, the PED virus (PEDV) was isolated by Pensaert and de Bouck [2] at Ghent University in Belgium. Since then, PEDV-associated diarrhoea has been widely detected in Europe. In Asia, it was reported in 1982 [3], and it has subsequently greatly impacted the Asian pork industry. In China during 2010 and 2011, over one million nursing piglets were lost due to PEDV-associated diarrhoea [4]; in 2013, PEDV emerged in

Korea and the USA [5–7] as well as in Taiwan [8], causing great economic losses and continu- ing to spread as an epidemic.

PEDV and transmissible gastroenteritis virus (TGEV) are members of the Coronaviridae family and the alpha coronavirus group. The PEDV genome consists of a positive single- stranded RNA approximately 28 kb in length that contains 7 open reading frames (ORF), including ORF1a, ORF1b, and ORF2-6 [9]. The viral particles are coated with S-protein, a type

I membrane protein. The protein forms spikes on the viral surface that are used to infect host cells and also bears highly antigenic domains and could theoretically be used to develop a high-titre neutralizing PEDV vaccine [6, 10]. However, Sun et al. [11] found that the sequence of this region is highly variable, a characteristic that is likely to reduce the efficiency of conven- tional commercial vaccines. Furthermore, the S-protein is a glycoprotein that undergoes com- plicated post-translational modifications that result in antigen diversity and create obstacles to the development of a PEDV vaccine [10].

The pathway of PEDV infection occurs mainly through the S-protein. PEDV first contacts sialic acids (neuraminic acid, NA) in host intestine [12] and then infects the villi by binding to aminopeptidase N (APN) on epithelial cells [13, 14]. These findings suggest that NA is the first glycoprotein receptor and that APN is the second one for PEDV during infection of the host intestine [15]. A similar process occurs during infection by TGEV [12]; on the other hand, porcine respiratory coronavirus (PRCV) loses its ability to infect the host intestine due to mutation and deletion of the S-protein genomic region occur [16]. Since viral genomic sequences of S-protein are generally variable and unstable, but in mammals, e.g., pigs, the codon sequences of their receptor are more stable and allow to be manipulated specifically by gene editing (GE). As mentioned above, PEDV infects the host via NA and APN, and NA has been shown to play an important role in host immune function and infection by pathogens [17, 18]. Human cells synthesize N-acetyl NA (NANA) but not N-glycolyl NA (NGNA), due to CMP-N-glycolylneuraminic acid hydroxylase (CMAH) insert an oxygen into the acetyl group of NANA converted to the glycolyl of NGNA [19] and the human CMAH gene has mutated during 2.5–3.0 million years of evolution [17]. We suggest that, analogous to the way in which human evolution has eliminated the NGNA receptor for PEDV, the CMAH gene of domestic pigs might be artificially mutated by gene editing technology to produce resistance to

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 2 / 25 [YHS]. After approval, the granting institution has no any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The co-author Dr. Chi-Min Chen is a virologist, especially on coronavirus and involved in the project by his responsibility to prepare the nv-PEDV and advice on the PEDV challenge procedures and the final pathological evaluation. He was our colleague but transferred to

Chao Kun Biotech Ltd. This commercial affiliation did not play a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript for the study. We declare that his role in this study has no conflicted interest and does not alter our adherence to PLOS

ONE policies or sharing data and materials. The co- author Dr. Chien-Hong Chen was also our colleague at ATRI and was responsible for zygotes micromanipulation to generate the CMAH KO pigs.

He has worked in the Reproductive Medicine Center of Lee Women’s Hospital after finished his duty in this project and without any interest conflicted to this study.

PEDV infection. The APN gene is not proposed as a target because it is essential for dipeptide digestion and amino acid absorption.

Currently available technologies for gene editing (GE) include the use of ZFN (zinc finger nuclease) [20], TALEN (transcription activator-like effector nuclease) [21], and CRISPR (clus- tered regularly interspaced short palindromic repeat)/Cas9 (CRISPR-associated (Cas) endori- bonuclease 9) [22]. Due to the availability of convenient techniques for constructing and editing vectors and the fact that Cas9 is a universal enzyme that can be constructed separately to guide/target vectors, use of the CRISPR/Cas9 system for GE is currently more popular than use of the ZFN and TALEN systems. Furthermore, GE can be simultaneously conducted on multiple sites or genes with the same Cas9 to achieve different targeting purposes or reduce the risks of off-targeting [23–25]. We have established TALEN [26] and CRISPR/Cas9 [27, 28] systems for direct microinjection of GE vectors to generate α1, 3-galactosyltransferase (GGTA1) mutant pigs. In this study, direct microinjection of two single-guide RNA and Cas9 mRNA vectors into the cytoplasm of pronuclear porcine embryos was used to generate

CMAH mutant pigs with null expression of NGNA, and the possibility of obtaining mutant piglets that are resistant to infection by PEDV was examined.

Materials and methods Animals and animal care Landrace mature gilts at least 120 to 150 kg in weight or sows and their neonatal piglets were used in this study. All animals were reared in a station free from specific pathogens (atrophic rhinitis, Mycoplasma hyopneumoniae, pseudorabies, Actinobacillus pleuropneumoniae, swine dysentery, scabies, classical swine fever, foot and mouth disease and porcine reproductive and respiratory syndrome). The gilts or sows were housed indoors on concrete floors, and the accommodation was artificially lit (450–600 lux for 9 hours a day) and exposed to window sun light. The animals were fed a restricted (4% body weight) commercial diet formulated to meet the requirements recommended by the National Research Council [29] and had ad libitum access to water.

All animals were managed and treated with permission from the Agricultural Technology

Research Institute (ATRI) (IACUC104004). The use of the animals and the PEDV challenge protocol, including the specific criteria used to determine when piglets should be euthanized, were approved by the confirmations of IACUC committee of ATRI (IACUC105063) and of

National Pingtung University of Science and Technology (NPUST) (NPUST-105-060). All the personal involved in the study have own a certificate from the experimental animal course in pig care or handling. Three in vivo PEDV-challenged experiments were conducted and in total of 60 piglets were used in this study. During the 3 days experiment, all animals’ health and behavior were monitored by the research staffs every 4 h and veterinarian once per day. Part of the piglets (1 KO and 3 WT in exp. I; 9 KO and 7 WT in exp. II; and 1 KO before and 1 KO in exp. III) died before meeting criteria for euthanasia (during 72 hpi of PEDV). During the in vivo experiments, welfare considerations also were taken, including efforts to minimize suffer- ing and distress and use of analgesics (3 mg/kg ketoprofen, intramuscular injection, once per day) if need. When piglets exhibited abnormal clinical behavior such as falling down and pumping, labored breathing, or sudden lethargy were observed, the animals shall be seen reached humane endpoint criteria and immediately euthanized by intramuscular injection of

5 mg/kg Zoletil (Virbac, France) and exsanguination.

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 3 / 25 Treatment of donors and recipients

Six donors were synchronized and induced to super-ovulate by being fed a ration supple- mented with Regumate (containing 0.4% Altrenogest; Intervet, MSD, France) for 15 days to synchronize their oestrus cycles and then being intramuscularly injected with PMSG (1,750

IU) and hCG (1,500 IU), 78 h apart, to induce oocyte maturation and ovulation. After hCG injection, the animals were artificially inseminated and sacrificed 30 to 36 h or 54 to 56 h later, and fertilized eggs were harvested from their oviducts. Three recipients were synchronized and ovulation-induced by the same methods as donors except that all treatments were delay 12 h and the dosage of PMSG and hCG was reduced to 1,500 IU and 1,250 IU, respectively, and insemination did not occur. When the fertilized eggs arrived at a nearby laboratory, CRISPR/

Cas9 RNA was microinjected into the cytoplasm; the eggs were then surgically transferred to the oviduct of a recipient from the end of the infundibulum by exposure of the uterine horn and oviducts within 3 to 4 h. The recipients were raised normally but treated with special care, particularly during farrowing.

Pig embryo manipulation and microinjection The recovered newly fertilized eggs were centrifuged at 15,000xg for 10 to 15 min at 25˚C to expose their pronuclei. The pronuclear embryos were added to a 20 μL microdroplet of D-PBS in a glass slide chamber and covered with mineral oil. The micro-manipulation was conducted under an inverted DIC (differential interference contrast) microscope at 200 to 300 x magnifi- cation. Each embryo was held in the proper position to reveal the pronucleus, and a mixture of single-guide RNA directed against two sites (sgRNA, 10 ng/μL each) and Cas9 RNA (70 ng/ μL) was microinjected into the cytoplasm near the pronucleus using a capillary needle with steady flow.

Animals breeding The confirmed CMAH KO pigs (founders) were raised by following the husbandry practices for breeding stocks of SPF herd. When reached puberty and showed their second estrous cycle, the females were thereafter estrus synchronized by Regumate feeding and withholding.

The female founders were then artificially inseminated with fresh extended semen collected from the male littermate founder to generate homozygous offspring for the study.

Construction of CMAH gene-specific sgRNA knockout and Cas9 vectors

The codon region of the porcine CMAH gene includes 14 exons; exon 1 contains 8 bp, and exon 2, which is 204 bp in length, is the largest exon (Fig 1, large capital letters shaded in yel- low). After verifying the sequences of exon 2 and introns 1 and 2 of the CMAH gene, we chose two GN19NGG Cas9 specific sequences; one of these has a sense strand site on exon 2, and the other has an antisense strand site located on intron 2 (Fig 1, characters underlined in red).

According to the sequences of the selected sites, two synthetic DNA primer pairs (shown in

Table 1) were annealed as double-stranded DNA fragments, digested with BsalI and cloned into the ppU6-(BsaI)2-sgRNA vector [30]; in this way, two sgRNAs, ppU6-(CMAH ex2)- sgRNA and ppU6-(CMAH in2)-sgRNA, were constructed. Cas9 in the pCX-Flag2- NLS1-Cas9-NL-S2 vector was constructed by Su et al. [30]. To make it possible to use the

RNAs for gene editing, pT7-Flag2-NLS1-Cas9-NLS2-3’pA, pSP6-(CMAH ex2)-sgRNA and pSP6-(CMAH in2)-sgRNA were constructed for in vitro transcription (S1 Fig). To prepare capped and poly-A tailed Cas9 mRNA, HindIII linearized pT7-Flag2-NLS1-Cas9-NL-S2-3’pA

DNA template was transcribed by mRESSAGE mMACHINE T7 Transcription Kit (Ambion,

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 4 / 25 AM1344, Carlsbad, CA, USA). To prepare CMAH single-guide RNAs, both of the BglII linear- ized pSP6-(CMAH ex2)-sgRNA and pSP6-(CMAH in2)-sgRNA DNA templates were tran- scribed by MEGAscript SP6 Kit (Ambion, AM1330, Carlsbad, CA, USA). All of the transcribed RNA products were further purified by the MEGAclear Transcription Clean-Up

Kit (Ambion, AM1908, Carlsbad, CA, USA) for microinjection.

Screening of CMAH gene mutant pigs Genomic DNA of all pigs delivered from foster dams or founders was isolated from tissue obtained from the piglet’s tails and purified using a genomic DNA purification kit (Fermentas/

Thermo). The CMAH mutant pigs were first screened by PCR using 0.1 μg of genomic DNA and 0.25 μM each of CMAH Ex2 F (TGGAGCTGTCAATGCTCAGG) and CMAH Ex2 R (TCA

GAGAGCTGCCGTAAAGG) primers (Fig 1) annealed at 55˚C. Wild-type or site-mutated pigs produced a ~439-bp amplicon, and biallelic simultaneously mutated animals displaying the

161-bp deletion produced a ~278-bp amplicon. For further confirmation, all PCR products were verified by PCR product-direct sequencing (PDS) and PCR product/TA cloning/ sequencing (PTS); from the latter, at least 6 colonies were picked and sequenced. DNA primer synthesis and DNA sequencing were conducted by Mission Biotech Ltd. (Taipei, Taiwan). The sequencing data were analysed using BioEdit software.

Fig 1. Construction of CMAH gene-edited vectors. The porcine CMAH gene editing sites were designated on exon 2 (sense strand, red capital letters underlined in red) and intron 2 (antisense strand, red letters underlined in red). The sequences underlined in black are PCR primers (CMAH Ex2 F and CMAH Ex2 R). The sequences shown in large capital letters with yellow shading are exon 2. The blue arrows indicate the gene editing sites. https://doi.org/10.1371/journal.pone.0217236.g001

Table 1. Primer pairs used to construct sgRNA expression vectors.

Primer Sequence pCMAH exon 2F CGTC GAAGCTGCCAATCTCAAGGA GTTTTAGAGCTAGAAAT pCMAH exon 2R

TGCTATTTCTAGCTCTAAAAC TCCTTGAGATTGGCAGCTTC pCMAH intron 2F

CGTC GATCGCCAGGGAGAAAGCAA GTTTTAGAGCTAGAAAT pCMAH intron 2R

TGCTATTTCTAGCTCTAAAAC TTGCTTTCTCCCTGGCGATC https://doi.org/10.1371/journal.pone.0217236.t001

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 5 / 25 Analysis of NGNA/NANA by HPLC Samples of ear, tail and small intestine weighing approximately 100 mg were cut into small pieces in MQ water and incubated at 95˚C for 30 min. After the samples had cooled to room temperature, 0.5 M H2SO4 was added to a final concentration of 25 mM. The mixtures were incubated at 80˚C for 1 h to release the sialic acids from the samples. After centrifugation, the supernatant was collected, an equal volume of DMB (1,2-diamino-4,5-methylenedioxyben- zene, Sigma-Aldrich, Inc.) solution (1.6 mg DMB in 1 mL of 1.4 M acetic acid, 0.75 M

2-mecaptoethanol and 18 mM sodium hydrosulfite solution) was added, and the mixture was incubated at 80˚C for 2 h to label the sialic acids. The labelled NGNA and NANA used as stan- dards were prepared as 1 mg/mL solutions and reacted under the same labelling conditions.

The DMB-labelled sample was injected onto a Waters™HPLC system (Waters 2475 Multi- wavelength Fluorescence Detector, Waters 717 plus Autosampler and Waters 600 Controller) with the Discovery BIO wide Pore C18 (5 μm, 4.6 x 25 cm) column. The analysis was per- formed using an isocratic mobile phase of methanol:acetonitrile:H2O (7:9:84) at a flow rate of

0.6 mL/min; the fluorescence detector was set at an excitation wavelength of 373 nm and an emission wavelength of 448 nm. (dx.doi.org/10.17504/protocols.io.zd6f29e).

PEDV challenge Piglet treatment and facility.

All CMAH KO neonatal piglets (refer Results) were deliv- ered from three F0 female founders that were served by the male F0 founder; thus, all founders were half or full sibs. All founders were biallelic CMAH mutants carrying a biallelic 161-bp deletion (D/D type) or one allele deleted and the other mutated (D/M type) genetic back- ground. The D/D type and/or D/M type piglets were used as described in the experimental sec- tion. The control piglets were non-gene-edited piglets that were concurrently delivered from wild-type sows at the same farm.

PEDV challenge was conducted in a negatively air-conditioned animal facility at the

NPUST. The pens were equipped with stainless mesh floors that allowed the faeces to drop down to a collection plate. The room temperature was set at 30˚C, and each pen was equipped with two extra electric power bubs.

During 4 h shipping (from farm to challenge facility), the piglets were kept at 25˚C in dark containers. When they arrived at the challenge room, the mutant and wild-type piglets were grouped and placed in different pens. Approximately one hour later, all piglets were oral inoc- ulated with PEDV, which diluted in commercial baby formula that had been reconstituted with warm drinking water. In experiments I and II, the animals in each pen had free access to

200 mL of fresh prepared baby formula and clean tap water that was changed every 4 h. In exp.

III, PEDV was diluted with KO or wild-type sow’s milk obtained 2 days after parturition, and no milk was offered; instead, fresh drinking water was offered and changed every 4 hours.

Other treatments were as described in experimental design III.

Experimental design. Exp. I: Challenge of 2-day-old neonatal piglets with nv-PEDV.

In total, 6 D/D type and 6 wild-type piglets were used for PEDV challenge, and one D/D type and one wild-type piglet without virus treatment were used as controls; the latter were not housed with the infected piglets. All neonatal piglets were nursed for approximately 20 h to allow intake of colostrum and then delivered to a negatively air-conditioned facility.

Exp. II: Challenge of 3-day-old neonatal piglets with nv-PEDV. In this trial, 8 D/D and 1

D/M type mutant piglets and 9 wild-type piglets were used for PEDV challenge, and one D/D mutant piglet and one wild-type piglet without virus treatment served as controls. All of the neo- natal piglets were nursed for approximately 44 h to permit intake of colostrum and dam’s milk.

The detailed conditions of the PEDV challenge were the same as those used in experiment I.

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 6 / 25 Exp. III: Challenge of 2-day-old neonatal piglets with nv-PEDV followed by extended feeding of sows’ colostrum. In this trial, 8 D/D and 3 D/M type mutant piglets and 12 wild- type piglets were used for PEDV challenge, and one D/D type piglet and one wild-type piglet without virus treatment served as controls. All neonatal piglets were nursed for approximately

20 h to permit intake of colostrum and then delivered to a negatively air-conditioned facility.

In this trial, the piglets were orally inoculated with PEDV as in experiment I and II and were not fed commercial baby cow milk; instead, they were fed their dams’ or other founder’s milk that had been collected within 20 h. From 4 to 24 h post PEDV inoculation (hpi), the piglets were fed 20 mL of sow’s milk by hand every 4 h; whole milk was fed at 4 and 8 hpi, and skim milk was fed from 12 to 24 hpi. From 24 hpi to 72 hpi, 20 mL of lactated Ringer’s solution sup- plemented with 5% glucose was fed to each piglet every 4 h. The piglets were randomly allo- cated to sacrifice at 24 hpi (3 piglets), 48 hpi (3 piglets), or 72 hpi (6 piglets), and the small intestines were sampled.

Preparation of new variant-PEDV for use in PEDV challenge

The new variant-PEDV (nv-PEDV) was isolated from a field case that occurred at Jimei farm in Yunlin County in central Taiwan in February 2015. Almost all of the affected one- week-old piglets died of watery diarrhoea. The aetiology of the disease was confirmed to be a virulent strain of PEDV (it was thereafter designated the Jimei strain); the sequence of this strain is almost identical to that of the strain that caused the epidemic outbreak of PEDV in the US in 2014 [31]. Although nv-PEDV can replicate in the Vero cell line, the nv-PEDV used in the challenge was prepared by oral inoculation of new born piglets that had not received colostrum to maintain its pathogenicity. The piglets were raised in a warm isolated chamber and were hand-fed fresh milk every six hours. Diarrhoea began to occur at 16–20 h after viral inoculation. The piglets were sacrificed 16–24 h after the observation of diarrhoea symptoms. The small intestinal content was collected by injection of 50 mL of DMEM sup- plemented with 10x P/S into the lumen followed by massage and extrusion from one end to the other end. The intestinal content was filtered through stainless mesh to clarify the con- tent. Finally, the sample was centrifuged at 3000xg to precipitate all cellular debris, and the supernatant was collected and divided into 5-mL portions in sterile conical tubes. Three small fragments of intestine were subjected to paraffin-embedded tissue sectioning and IHC to confirm the presence of PEDV in intestinal epithelial cells (TGEV and rotavirus detection was also performed, and both tests were negative). A TCID50 was used according to stan- dard virological methods to determine the viral content of the Jimei PEDV virus prepara- tion used in the challenge study [32]. The virus was maintained at -80˚C until the challenge study was performed. Inoculation of the animals with PEDV was conducted as described by

Jung et al. [7]. In brief, 103 TCID50/mL of frozen nv-PEDV stock was thawed at hand tem- perature, and 10 mL of the thawed stock was mixed with 90 mL of reconstituted commercial baby milk or sow’s milk by repeatedly inverting the container. The CMAH mutant and wild-type piglets were inoculated with 103 TCID50/10 mL PEDV orally by hand using a syringe.

Clinical observations.

After inoculation with PEDV, the piglets’ behaviour, including vomiting, diarrhoea, and lethargy, was observed and recorded every 4 hours for 3 days. When the piglets died or at the end of the experiment, their body weights were recorded, and they were necropsied on the same day.

Sampling.

The intestines of all piglets were sampled at the upper and middle region of the jejunum and the upper part of the ileum by resecting a portion of the intestine approximately

10 cm in length. This piece was then ligated at both ends with surgical string, cut down, and a

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 7 / 25 suitable amount of 10% formalin was injected into the luminal space. The entire sample was then immersed in ~15 mL 10% formalin and fixed for at least for 24 hours.

Hematoxylin eosin (H/E) and immunofluorescence (IF) staining

After fixation, the samples of intestine obtained from the piglets were sliced, embedded in par- affin, and sectioned at 3 to 4 μm thickness. The sections were placed on slides, de-waxed in xylene and sequentially treated with 100%, 95%, 80% and 70% ethanol; the slides were then stained by H/E. For IF staining, the slides were de-waxed in xylene and 100% ethanol and fur- ther heated in boiling TAE buffer for 3 min to activate the antigen. After cooling to room tem- perature, the slides were washed with PBS for 15 min, and the tissues were stained with a primary antibody against PEDV (prepared by Dr. CM Chen) and a commercial secondary antibody, FITC-conjugated goat anti-mouse immunoglobulin (Cappel). After immersion in

DAPI solution, the slides were sealed with 10% glycerol, and the signals were observed on an

Olympus BX50 microscope (Olympus, Japan) enlighten by UV-light.

Pathology evaluation The criteria used to score immunofluorescence (IF) staining and histopathological lesions (I/

H score) associated with PEDV are shown in Fig 2. PEDV mainly infects the epithelial cells that form the mucosa of the small intestine. Each part of the small intestine was evaluated at three different locations and their mean represented one piglet data. In the early stage of

PEDV infection, only IF staining allows us to observe whether or not epithelial cells have been infected by PEDV. Therefore, at that stage, the percentage of IF-positive cells was the only cri- terion used to determine the severity of PEDV infection. However, in the middle to late stages of infection, the severity of PEDV infection is better judged by the degree of villar atrophy because infected cells often defoliate from the mucosa and IF may not reveal the PEDV- infected cells. Therefore, the lesions were scored from 1 to 5 as shown in Fig 2C; the scores combined the results of both IF staining and histopathological inspection in an I/H score that was used in the final statistical analysis.

Statistical analysis All of the clinical and viability data were recorded and analysed using GraphPad Prism 6 (GraphPad Software, Inc.). The survival rate (curves) of the piglets after PEDV challenge was analysed using the Log-rank (Mantel-Cox) and Gehan-Breslow-Wilcoxon tests. The t-test was used to analyse the body weight and immune/histopathologic data obtained from the intestinal samples from all experimental piglets. The significance level () was set at 0.05.

Results Generation of CMAH mutant pigs A total of 70 zygotes (Table 2) were microinjected with the CRISPR RNA, including two sgRNA, which are directed against two sites on CMAH within exon2 and intron 2 (Fig 1), and

Cas9 mRNA and transferred to 3 foster dams. Five live piglets and 1 stillborn piglet were deliv- ered by one pregnant sow (Table 2). PCR analysis of CMAH KO revealed that 1 male (L667- 02) and 3 females (L667-10, -11, and -12) (Fig 3A) carried 161-bp deletion mutations (Fig 3B).

Further analysis by PCR-directive sequencing (PDS) and subcloning of PCR products in T-A cloning vectors and sequencing (PTS) showed that the 4 live piglets and the stillborn piglet were biallelic CMAH mutants; of these, L667-02 was biallelic 161-bp deleted (D/D type) (Fig

4A), L667-10, -11 and -12 were mosaic with D/D type and 2 sites mutated (D/D and D/M

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 8 / 25 Fig 2. Evaluation criteria based on immunofluorescence staining and histopathological lesions (I/H score) of piglets’ intestine samples after PEDV challenge. A.

KO0 or WT0 controls for the ground state, G0. B. IF is scored as G1 to G4 based on the relative intensity of staining, whereas G5 is based on villar atrophy or defoliation observed by H/E inspection. The corresponding scores are shown in C. The arrows indicate necrotic villi; the yellow bars represent 200 μm. https://doi.org/10.1371/journal.pone.0217236.g002

Table 2. Generation of CMAH knockout (KO) pigs by direct microinjection of sgRNA/Cas 9 mRNA into the cyto- plasm of pronuclear newly fertilized porcine eggs.

Micromanipulation No. of surrogate No. of piglets Lot

No. of zygotes Dam Pregnant (%) Borna KO (%) BKOb(%)

1 31 1 1 5/1 5 (83.3) 5 (83.3) 2 21 1 0 0/0 0 (0) 0 (0)

2 18 1 0 0/0 0 (0) 0 (0) Total 70 3 1 (33.3) 5/1 5 (83.3)

5 (83.3) a. alive/dead b. biallelic knockout. https://doi.org/10.1371/journal.pone.0217236.t002

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 9 / 25 types) (Fig 4A–4C), and the stillborn animal (L667-D) had a single base mutation and a 5-bp insertion at site I and a 5-bp deletion at site II (M/M type) (Fig 4B and 4C). The efficiency of gene editing and KO was 7.5% based on the number of manipulated embryos and 83.3% based on the number of delivered piglets, all of which were biallelic mutants (Table 2).

The animals used for PEDV challenge were obtained by breeding the three founders (L667- 10, 11 and 12) with the founder boar (L667-02). The mutational status of their offspring (Table 3) was confirmed by PCR, PDS and PTS (S2–S4 Figs). All piglets were rapidly screened by PCR, and D/D piglets were preferentially used in the experiments. In exps. II and III, the D/

D piglets were supplemented with 1 and 3 D/M type piglets, respectively (Table 4) that were confirmed by PTS to have 1-bp insertions or 14- or 2-bp deletions at site I on the mutated chromosome (S2–S4 Figs). The null expression of the CMAH gene was analysed based on the detection of NGNA/NANA by HPLC; the results showed that all founders (Fig 5) and their

Fig 3. Generation of CMAH gene-edited pigs. A. Four lines of CMAH gene-edited piglets (1 male, L667-02, and 3 females, L667-10, 11, and 12) were obtained. B.

CMAH KO piglets were analysed and screened by PCR. The amplicons were produced a 161-pb deleted band when two sites editing occurred simultaneously. https://doi.org/10.1371/journal.pone.0217236.g003

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 10 / 25 Fig 4. Genotyping by TA-cloning and sequencing of the porcine CMAH gene edited by CRISPR/Cas9 vectors directed against two sites. A. The genotype shown displays two simultaneously mutated sites and a deleted 161-bp DNA fragment; the blue A represents an extra inserted base that appeared in L667-12. B. The indel occurred at site I of exon II of the CMAH gene. C. Details of the mutation at site II of intron 2 of the CMAH gene.

The blue arrows and lines indicate the cutting site of Cas9. The blue letters represent inserted bases, and the dashed line indicates deleted bases. https://doi.org/10.1371/journal.pone.0217236.g004

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 11 / 25 offspring (S5 Fig) lacked NGNA expression. These results show that all founders and their off- spring are biallelic mutants that fail to express CMAH and produce no NGNA in their tissues.

Clinical observation of neonatal piglets challenged with nv-PEDV

Exp. I: When neonatal 2-day-old piglets were challenged with nv-PEDV, both the CMAH mutant (Knockout, KO) and wild-type (WT) animals initially displayed clinical signs of

Table 3. Germline transmission and genotypes of F1 CMAH KO piglets.

Sow Parity Litter size m/f/d(n)a Birth weight (Mean±SE), kg

No. of piglets of KO genotypeb D/D (-161/+1/-5) D/M (site I)

L667-10 (-14 bp) 1 12 5/5/2 (3) 1.43 ± 0.16 6 (5/1/0)

6 2 8 5/3/0 (0) 1.76 ± 0.08 7 (7/0/0) 1 3 12 3/6/3 (0)

1.53± 0.06 9 (9/0/0) 3 L667-11 (+1 bp) 1 6 4/1/1 (0)

1.77 ± 0.05 4 (4/0/0) 2 2 6 4/2/0 (0) 1.76 ± 0.10 3 (3/0/0)

3 3 1 0/0/1 (0) 1.72 1 (1/0/0) 0 L667-12 (-2 bp) 1

13 7/3/3 (3) 1.46 ± 0.10 13 (7/5/1) 0 2 13 8/4/1 (0)

1.57 ± 0.08 11 (6/3/2) 2 3 12 6/3/3 (0) 1.62 ± 0.07

10 (5/3/2) 2 Sum 58 33/18/7 (6) 1.58 ± 0.04 17 11/5

8 a. m/f/d (n): No. of males/females/stillbirths (n = live piglets that died due to weakness). b. Genotypes: D indicates deleted and M refers a site I mutation in exon 2 and null CMAH expression. D/D type: -161 indicates a genomic type featuring a 161-bp deletion in which the mutation at sites I and II occurs simultaneously on both chromosomes; +1 indicates the indel with a 161-bp deletion and a 1-bp insertion (+1); and -5 indicates the presence of a 161-bp deletion with simultaneous deletion of 5 additional bp (-5 bp). D/M type: -161 bp/ site I mutated; in parentheses, -14 bp indicates a 14-bp deletion, +1 bp indicates a 1-bp insertion, and -2 bp indicates a 2-bp deletion. https://doi.org/10.1371/journal.pone.0217236.t003

Table 4. Genotypes of the F1 CMAH KO piglets used for PEDV challenge.

Exp.

Sow/ L667- Genotype Site I of Mutant allele Parity

ID.

Litter size D/D D/M 1 1 10 12 1 0 - 11 6 2 0 - 12 13

3 0 - Control 12 1 0 - 2 2 10 8 3 0 - 11 6 3 1 +1 12

13 2 0 - Control 12 1 0 - 3 3 10 12 4 2 -14 11 1 0

0 - 12 12 5 1 -2 Control 10 1 0 - Note: Genotypes: D indicates that the mutation occurred at two sites simultaneously and resulted in a 161-bp deletion, whereas M is site I-mutated, on codon region and null CMAH expression; D/D refers to the case in which the 161-bp deletion occurred on both chromosomes. The controls are wild-type piglets. https://doi.org/10.1371/journal.pone.0217236.t004

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 12 / 25 vomiting and diarrhoea at 12 hours post-inoculation (hpi), and their activity also decreased (Table 5). In the WT group, the first piglet’s death occurred at 44 hpi; a second animal died at

52 hpi, a third at 68 hpi, and the remaining three animals were moribund and nearly dead at

72 hpi (Fig 6A). In the CMAH KO group, the first piglet died at 60 hpi, 3 piglets were mori- bund at 72 hpi, and the other remaining two piglets survived until the end of the trial (Fig 6A and Table 5). After nv-PEDV inoculation, the loss of body weight of WT piglets was 0.69±0.04 kg, significantly (p<0.01) greater than that of CMAH KO piglets (0.45±0.03 kg) (Fig 7A).

Exp. II: The 3-day-old piglets were examined as in exp. I. Although both CMAH KO and

WT animals initially showed clinical signs of vomiting and diarrhoea at 12 hpi, 2 KO and 4

WT piglets were without clinical signs (Table 5). Furthermore, all piglets sustained their activ- ity until 24 hpi (Table 5). In the WT group, the first death occurred at 40 hpi (Fig 6B); two pig- lets were lost at 48 hpi, 4 piglets died at 56 hpi, and the remaining two piglets were alive at the end of the trial. In the CMAH KO group, the first animal was lost at 44 hpi, and 3, 3, 1 and 1 piglets died at 52, 56, 64 and 68 hpi, respectively (Fig 6B). There was no significant difference

Fig 5. Expression of NGNA/NANA in the tissues of CRISPR/Cas9 CMAH mutant founders. L667-02, -10, -11 and -12 and their wild-type littermate (L667-01) were analysed by HPLC. NGNA STD and NANA STD are standard samples of NGNA and NANA, respectively. The blue line indicates a retention time of 10 min. https://doi.org/10.1371/journal.pone.0217236.g005

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 13 / 25 in the decrease in body weight in the two groups of piglets (WT/ -0.60±0.02 kg vs. CMAH

KO/-0.55 ±0.04 kg; p> 0.05) (Fig 7B).

Exp. III: To examine the early events and the role of NGNA in nv-PEDV infection of neo- natal piglets, we used 2-day-old piglets challenged with nv-PEDV. After infection, the piglets were fed sows’ milk and skim milk every 4 hours for 24 hours; this was then replaced by Ring- er’s lactate solution supplemented with 5% glucose, and the piglets were sacrificed at 24, 48 and 72 hpi. The results (Table 6) show that until 12 hpi both the CMAH KO and WT piglets appeared normally active; however, with respect to clinical signs, only 3/11 CMAH KO piglets did not show diarrhoea or vomiting at 12 hpi. From 4 to 24 hpi, all piglets were fed their own dams’ whole or skim milk; the results show that all piglets displayed decreased activity and diarrhoea without a significant difference between CMAH KO and WT piglets. One moribund

CMAH KO piglet was observed at 44 hpi, and one moribund WT piglet was observed at 56 hpi; all of the piglets stopped vomiting after 24 hpi. After the sow’s milk was replaced with

RLG, all piglets (both CMAH KO and WT) showed sustained activity and viability at least until 56 hpi, with the exception of one CMAH KO piglet that died prior to the end of the trial (Table 6).

Immuno/Histopathology of neonatal piglets challenged with nv-PEDV

After 72 hpi, all of the dead and euthanized piglets were necropsied, and their intestines were sampled for pathological examination. Grossly, the small intestine appeared transparent and orange-yellow to flesh pink in colour; it was thin-walled and dilated with fluid content in the live piglets (S6A and S6B Fig). In exp. I, the PEDV induced histopathologic changes, including enterocyte necrosis, degeneration, and exfoliation, and collapsed lamina proprial tissues con- taining karyorrhectic debris, were noted in all challenged piglets. However, these lesions varied from mild to severe, and the lesions were more severe in the moribund WT piglets than in the

CMAH KO piglets (Fig 8). Immunofluorescence (IF) staining with a monoclonal antibody against PEDV nuclear protein was used to detect PEDV antigens. The results showed that

PEDV antigen was presented in the epithelium covering the moderately atrophic tips of villi in the small intestine of WT and CMAH KO piglets (Fig 9). However, if the epithelial cells were defoliated from the villi after PEDV infection, no positive signals would be expected (Fig 9A).

We further scored the severity of lesions in the intestines of the infected animals (Fig 2) by a combination of IF staining and histopathological inspection (immuno/histopathological, I/H, score). According to I/H scores, results revealed that the severity of the intestinal lesions in KO

Table 5. Clinical signs displayed by neonatal piglets after nv-PEDV inoculation in Exps. I and II.

Exp.

Geno-type No.

Hours post nv-PEDV inoculation 4–8 12 24 36 48 60 72

I KO 6 6A/ 6B/ 6B/ 1A5B/ 6B/ 4B1C1D/ 2B3C1D/ 6n 2d4dv

3n3d 4n2d 3n3d 1n4d 5d WT 6 6A/ 6B/ 2B4C/ 5B1C/ 4B1C1D/

1B3C2D/ 3C3D/ 6n 6dv 2n4d 6d 2n2d1dv 4d 3d II KO 9

9A/ 9A/ 9B/ 9B/ 6B2C1D/ 1B1C7D 9D/ 9n 2n1v2d4dv 2n6d1dv

9d 8d 2d 0 WT 9 9A/ 9A/ 9B/ 9B/ 5B2C2D/ 2B7D/ 1B1C7D/

9n 4n3v1d1dv 1n8d 1n8d 7d 2d 2d Note: No. of piglets with viability and clinical signs: viability—A is normal, B indicates decreased activity, C is moribund, and D indicates dead; clinical signs—n indicates no clinical signs, d is diarrhoea, and v is vomiting. https://doi.org/10.1371/journal.pone.0217236.t005

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 14 / 25 Fig 6. Survival of neonatal piglets after oral inoculation with nv-PEDV. A (Exp. I), 2-day-old piglets’; and B (Exp. II), 3-day-old neonatal piglets’ survival curve after inoculated with nv-PEDV. Solid circles (A) or squares (B) with lines represent the CMAH KO piglets, and open diamonds (A) or squares (B) with dashed lines indicate wild-type piglets. The arrow shows the time of inoculation. In A at 72 hpi, three moribund WT piglets are classified as dead piglets. https://doi.org/10.1371/journal.pone.0217236.g006

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 15 / 25 piglets (3.7±0.3 to 4.2±0.2) less than those in WT piglets (4.8±0.2) (p<0.05) in exp. I; but there were no significant difference among WT piglets (from 3.4±0.6 to 4.4±0.3) and CMAH KO piglets (from 4.3±0.4 to 4.7±0.2) in exp. II (Table 7). In exp. III, even ruling out the possible effects of feeding the animals with commercial baby cow milk, we also found no significant dif- ference in I/H scores of WT and CMAH KO piglets (Table 8). According to the I/H scores obtained at 72 hpi, which ranged from 3.8±0.4 to 3.2±0.5 in CMAH KO piglets and from 2.8

±0.4 to 2.5±0.2 in WT piglets (p>0.05), most piglets seemed to improve compared with those at 24 and 48 hpi when offered sow’s milk and supplemental lactated Ringer’s solution contain- ing 5% glucose (Table 8).

Fig 7. Body weights of neonatal piglets before and after oral PEDV inoculation. A. 2-day-old piglets (n = 6) and B. 3-day-old piglets (n = 9) in Exp. I and Exp. II, respectively, show body weights changes 72 h after inoculated with nv-PEDV. K0 and W0 represent KO and WT animals that were not inoculated with PEDV and were reared by their dams on the farm. KO and WT are knockout treated and wild-type treated animals, respectively. https://doi.org/10.1371/journal.pone.0217236.g007

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 16 / 25 Discussion Currently, gene editing is widely used in both basic and applied studies, e.g., in studies of the disease resistance of farm animals [33]. One convincing report showed that CD163 gene- edited pigs generated by CRISPR/Cas9 exhibited physiological normality and showed little vul- nerability to porcine reproductive and respiratory syndrome virus (PRRSV) infection either in vitro [34] or in vivo [35–37]. However, other attempts, including putative receptors of CD169

KO and CD163 KO, failed to produce evident resistance to PRRSV [38] or African swine fever [39], respectively. These failures may have occurred because the mechanism of viral infection involves other receptors or because it does not involve receptors [38].

The hypothesis that the absence of NGNA expression in CMAH KO piglets disables PEDV infection was partially proven in this study. In exp. I, 2-day-old old piglets were orally inocu- lated with the local outbreak strain nv-PEDV [31]. Although the final (72 hpi) survival rate dif- fered little in the WT and KO animals, based on the histopathologic examination and considering the 3 deadly moribund WT piglets, the CMAH KO piglets showed greater resis- tance to nv-PEDV infection than the WT animals. This assumption is supported by the high degree of histopathologic severity found in the WT piglets, which clearly differed from that observed in the CMAH KO piglets. However, when 3-day-old piglets were used, no differences between CMAH KO and WT piglets were observed. It is doubtful that the NGNA present in cow’s milk-based formula would enable the virus to infect the CMAH KO piglets. In exp. III, colostrum from the KO or WT sows was given to avoid any possible NGNA inference, yet the final susceptibilities of the two genotypes were similar, due to no or little NGNA (S7 Fig).

However, at least 3 of the 11 CMAH KO piglets showed normal activity and no clinical signs (no vomiting or diarrhoea) at 12 hpi, whereas the WT piglets displayed vomiting and/or diar- rhoea. Lessened severity was therefore observed.

Considering that transmissible gastroenteritis virus (TGEV) and other coronaviruses use sialic acid (neuraminic acid, NA) and APN as their first [12,15] and second receptors [13,15],

PEDV might act in a similar manner. Recently, the domain VII of APN was suggested to play a critical role for PEDV binding [40]; yet, when the ANPEP (APN) was null mutated by using

Table 6. Clinical signs displayed by neonatal piglets after nv-PEDV inoculation in Exp. III.

Geno-type h No.

Hours post nv-PEDV inoculation 4–8 12 16 20 24 28–40

44 48 56 64 72 KO 24 3 3A/ 3A/ 3B/ 2B1C/ 3B/ - - - - - - 3n

2n1v 3d 1v2d 3d 48 2# 2A/ 2A/ 2B/ 2B/ 2B/ 2B/ 1B1C/

2B/ - - - 2n 1n1v 2d 1d1dv 2d 2d 1n1d 1n1d 72 6 6A/

6A/ 6B/ 6B/ 6B/ 6B/ 6B/ 6B/ 4B2C/ 3B3C/ 3B2C1D 6n 4v1d1dv

6d 6d 6d 6d 6d 6d 6d 6d /5d WT 24 3 3A/ 3A/ 3B/ 2B/

3B/ - - - - - - 3n 2v1dv 3d 2d1dv 3d 48 3 3A/ 3A/ 3B/

3B/ 3B/ 3B/ 3B/ 3B/ - - - 3n 1v1d1dv 3d 3d 3d 3d 3d

3d 72 6 6A/ 6A/ 6B/ 6B/ 6B/ 6B/ 6B/ 6B/ 5B1C/ 4B2C/

5B1C/ 6n 2v4dv 6d 6d 6d 6d 1n5d 6d 6d 6d 6d Note: No. of piglets with viability and clinical signs: viability—A is normal, B indicates decreased ability, C is moribund, and D is dead; clinical signs—n indicates no clinical signs, d is diarrhoea, and v is vomiting.

# One piglet died before experiment. https://doi.org/10.1371/journal.pone.0217236.t006

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 17 / 25 Fig 8. Pathological inspection of piglets’ intestine at the middle jejunum by H/E staining. Panels A. and B. indicate wild-type and knockout piglets, respectively, after PEDV oral inoculation. C. The samples from control, the best and the worst pathological responded piglets, which are no nv-PEDV-inoculated, survival and dead, respectively, at 72 hpi. The upper panels (WT0, WT5 and WT6) are samples from wild type piglets and the down panels (KO0, KO4 and KO6 are samples from CMAH KO piglets. Arrows indicate epithelial cells and the yellow bars indicate 200 μm. https://doi.org/10.1371/journal.pone.0217236.g008

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 18 / 25 CRISPR/Cas9 editing, the KO piglets though not infected by TGEV but still vulnerable to

PEDV [41]. We found the major components of porcine mucin in the small intestinal submu- cosa are two types of NA, N-acetylneuraminic acid (NANA) and N-glycolylneuraminic acid (NGNA) (unpublished data). Using a glycan screening array, Liu et al. [42] showed that

Neu5Ac (or NANA) has the highest binding affinity for PEDV S1-NTD-CTD; however, they also found that porcine mucin or bovine mucin could inhibit or block in vitro PEDV and

TGEV infection of PK-15 or Huh-7 cells which transfected with porcine APN. The present results show that CMAH KO piglets exhibited delayed infection and minor symptoms after oral PEDV inoculation, suggesting that in CMAH KO piglets that are normally nursed, PEDV

Fig 9. Immunofluorescence staining with an antibody against nv-PEDV N protein. WT3 (A) shows a sample from a wild-type piglet, and KO3 (B) shows a sample from a double-chromosome CMAH gene knockout piglet. The samples shown in the upper, green colour, and lower, blue colour, panels are fluorescent stained with nv-PEDV antibody and DAPI, respectively. The yellow bars indicate 200 μm. https://doi.org/10.1371/journal.pone.0217236.g009

Table 7. The immunofluorescence and histopathological (I/H) score of piglet small intestine at 72 h after oral

Inoculation of 2 (I)- or 3 (II)-day old neonates with PEDV.

Exp.

Genotype n Jejunum Ileum Front Middle I KO 6 4.0±0.3b

4.2±0.2b 3.7±0.3b WT 6 4.8±0.2a 4.8±0.2a 4.8±0.2a II

KO 9 4.3±0.4 4.7±0.2 4.4±0.4 WT 9 4.4±0.3 3.4±0.6 3.6±0.6

KO = CMAH KO homozygotes, WT = wild-type piglets. a, b. In exp. I, means between the same columns differ significantly (p<0.05). https://doi.org/10.1371/journal.pone.0217236.t007

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 19 / 25 may be unable to bind efficiently to the APN on the villi of epithelial cells and pass through the intestinal lumen. The infection of virus via receptor could be the sole route for PRRSV [35–37] and TGEV [12,15,41], but not true for PEDV, might be through a more complicate mechanism other than receptors [43].

It is known that PEDV causes severe enteric disease in suckling piglets [44,45] and less severe disease in older weaned pigs [46]. Our results suggest that the differentiation might occur as early as in the neonatal period; clinical diarrhoea and/or vomiting and decreased activity were observed in all 2-day-old piglets but improved in 3-day-old piglets. When caesar- ean-delivered and colostrum-deprived (CDCD) animals were used for oral inoculation of

PEDV, the 1-day-old piglets showed clinical signs at 12 hpi [47]; this was also observed in our study using naturally delivered piglets. Furthermore, in PEDV inoculation studies, 5-day-old

CDCD piglets were more sensitive than 21-day-old weaned piglets [32]. Similarly, naturally delivered 9-day-old suckling piglets showed a weaker innate immune response to PEDV than weaned pigs [48]. This study used 2- or 3-day-old piglets that were naturally delivered and nursed with colostrum by CMAH KO or WT sows prior to PEDV oral inoculation in an attempt to realize the protective effects of nursing in animals in which the biallelic CMAH genes were mutated. In exp. III, the clinical symptoms of 2-day-old piglets that were PEDV inoculated and hand fed whole or skim sow’s milk for an additional 24 h were similar to those of the 3-day-old piglets in exp. II. Furthermore, when lactated Ringer’s solution supplemented with 5% glucose was offered from 24 to 72 hpi, the epithelial cells of the villi showed less dam- age and/or showed increased recovery of epithelial cells from the crypts according to the I/H scores, which ranged from 4.0 ± 0.0 to 2.5 ± 0.2 in WT piglets and from 5.0 ± 0.0 to 3.2 ± 0.5 in the KO group. This benefit of oral rehydration therapy in acute viral diarrhoea could be attrib- uted to glucose-facilitated sodium absorption [49] and to alleviate Na+-K+-ATPase and Ca2

+-Mg2+-ATPase damage [50]. Currently, the model may be improved by inoculating the piglets and allowed them to be continually nursed by dams of the same genotype to avoid NGNA interference.

In addition to their disease resistance, CMAH and GGTA1 KO animals are likely to display reduced hyperacute rejection of xenografts [51]. Our unpublished data also revealed that the acellular extracellular matrix derived from the intestine of CMAH KO pigs caused significantly less inflammation than that obtained from WT pigs after intramuscular implantation into

CMAH/GGAT1 double KO pigs. Furthermore, NGNA present in red meat has been suggested to be a risk factor for human colorectal cancer and atherosclerosis in persons who habitually consume red meat [52]. Therefore, CMAH mutant pigs generated by GE can be viewed as pigs

Table 8. Intensity of PEDV infection of epithelial cells of villi in CMAH KO piglets’ intestines revealed by immunofluorescence and histopathological (I/H) score. hpi1

Genotype2 No. of piglets Jejunum Ileum.

Front Middle 24 KO 3 5.0±0.0 5.0±0.0 3.3±0.9 WT 3 3.0±1.0

4.0±0.6 3.7±0.9 48 KO 2 4.0±0.0 4.0±0.0 4.0±0.0 WT

3 4.0±0.0 4.0±0.0 3.7±0.3 72 KO 6 3.2±0.5 3.8±0.4 3.3±0.6

WT 6 2.5±0.2 2.8±0.4 2.5±0.3 1. hpi = hours post inoculation.

2. KO = CMAH gene knockout by gene editing; WT = wild-type piglets. https://doi.org/10.1371/journal.pone.0217236.t008

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 20 / 25 that offer a source of healthy red meat and of material that is suitable for use in biomedical devices.

In conclusion, the CMAH mutant pigs generated by gene editing could be a new breed with less susceptibility to PEDV, a source animal for medical materials and xenografts, and a source of healthy red meat.

Supporting information S1 Fig. Representative map of the pT7-Flag2-NLS1-Cas9-NLS2-3’pA and pSP6-CMAH- sgRNA vectors. T7 and SP6 promotors are used for in vitro transcription Cas9 mRNA and

CMAH-sgRNA, respectively. NLS1 and NLS2 are nuclear localization sequences [30]. EcoRI,

MluI, Acc65I, HindIII, BamHI and BglII are restriction enzyme sites. Amp is ampicillin resis- tance gene for plasmid selection during vectors constructing. Flag tag was used for assess Cas9 protein expression. (TIF)

S2 Fig. Analysis of CMAH gene-edited offspring from the first parity. A. The PCR products that revealed more than one band were further subcloned into the TA vector for colony purifi- cation and sequencing. B. Offspring with mutations at site I (exon II) and site II (intron 2). C.

The offspring carrying two sites mutated simultaneously, with deletion of a 161-bp DNA frag- ment, and some of them showed further indel of +1 or -5 bp. D1 –D5 are stillborn piglets. In

PCR, + and −are reaction positive and negative control. (TIF)

S3 Fig. Analysis of CMAH gene-edited offspring from the second parity. A. The PCR prod- ucts that revealed more than one band were further subcloned into the TA vector for colony purification and sequencing. B. Offspring with mutations at site I (exon II) and site II (intron

2). C. The offspring carrying two sites mutated simultaneously, with deletion of a 161-bp DNA fragment, and some of them showed further indel of +1 or -5 bp. (TIF)

S4 Fig. Analysis of CMAH gene-edited offspring from the third parity. A. The PCR prod- ucts that revealed more than one band were further subcloned into the TA vector for colony purification and sequencing. B. Offspring with mutations at site I (exon II) and site II (intron

2). C. The offspring carrying two sites mutated simultaneously, with deletion of a 161-bp DNA fragment, and some of them showed further indel of +1 or -5 bp. (TIF)

S5 Fig. HPLC analysis of NGNA/NANA in the ear tissues of six F1 offspring of the CMAH

KO founders. The retention times of NGNA and NANA are shown as numbers on the peaks. (TIF)

S6 Fig. Gross appearance of the small intestine of neonatal piglets at 72 hpi or at the time of death during the trial. A. The KO0 and WT0 are control piglets without nv-PEDV inocu- lated. B. KO1 to KO5 are survival KO piglets. (TIF)

S7 Fig. Analysis of NGNA by HPLC on colostrum from KO and WT sows or commercial baby formula. The blue line show a non-specific peak with retention time (RT) at 9.51–9.52 min and appeared in all samples. The RT of NGNA peak are 9.671–9.737 min near the non- specific peak. STD means standard samples of NGNA or NANA. (TIF)

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 21 / 25 Acknowledgments The authors would like to express their sincere thanks to Mr. Chi-Yun Hsu, Mr. Shau-Ching

Hseu and Mr. Ci-Hong Wong for assistance with the care of the experimental animals, partic- ularly that of the KO pigs. Thanks are also expressed to Ms. Ming-Shing Liu for technical assis- tance with pig surgery and embryo transfer and to Dr. Chao-Nan Lin for his assistance with the PEDV challenge trial at the National University of Science and Technology.

Author Contributions Conceptualization: Ching-Fu Tu, Chin-kai Chuang, Tien-Shuh Yang, Chuan-Mu Chen.

Data curation: Ching-Fu Tu, Kai-Hsuan Hsiao, Chien-Hong Chen, Chi-Min Chen, Su-Hei

Peng, Yu-Hsiu Su, Ming-Tang Chiou, Chon-Ho Yen, Shao-Wen Hung.

Formal analysis: Ching-Fu Tu, Kai-Hsuan Hsiao, Chi-Min Chen, Su-Hei Peng, Yu-Hsiu Su,

Chon-Ho Yen, Shao-Wen Hung, Tien-Shuh Yang.

Funding acquisition: Ching-Fu Tu.

Investigation: Ching-Fu Tu, Chin-kai Chuang, Kai-Hsuan Hsiao, Chien-Hong Chen, Chi- Min Chen, Su-Hei Peng, Yu-Hsiu Su, Ming-Tang Chiou, Chon-Ho Yen, Shao-Wen Hung,

Tien-Shuh Yang.

Methodology: Ching-Fu Tu, Chin-kai Chuang, Kai-Hsuan Hsiao, Chien-Hong Chen, Chi- Min Chen, Su-Hei Peng, Yu-Hsiu Su, Ming-Tang Chiou, Chon-Ho Yen, Shao-Wen Hung.

Project administration: Ching-Fu Tu, Kai-Hsuan Hsiao.

Resources: Ching-Fu Tu, Chi-Min Chen, Ming-Tang Chiou.

Software: Shao-Wen Hung.

Supervision: Ching-Fu Tu, Chi-Min Chen, Tien-Shuh Yang, Chuan-Mu Chen.

Validation: Ching-Fu Tu, Chin-kai Chuang, Chi-Min Chen, Ming-Tang Chiou, Chon-Ho

Yen, Tien-Shuh Yang.

Visualization: Ching-Fu Tu.

Writing – original draft: Ching-Fu Tu, Kai-Hsuan Hsiao, Chi-Min Chen, Su-Hei Peng, Shao- Wen Hung, Tien-Shuh Yang, Chuan-Mu Chen.

Writing – review & editing: Ching-Fu Tu, Chien-Hong Chen, Chon-Ho Yen, Tien-Shuh

Yang, Chuan-Mu Chen.

References 1.

Lee C. Porcine epidemic diarrhea virus: an emerging and re-emerging epizootic swine virus. Virol J.

2015; 12: 193. https://doi.org/10.1186/s12985-015-0421-2 PMID: 26689811

2.

Pensaert MB, de Bouck P. A new coronavirus-like particle associated with diarrhea in swine. Arch Virol.

1978; 58: 243–247. PMID: 83132 3.

Chae C, Kim O, Choi C, Min K, Cho WS, Kim J, et al. Prevalence of Porcine epidemic diarrhoea virus and transmissible gastroenteritis virus infection in Korean pigs. Vet Rec. 2000; 147: 606–608. PMID:

11110482 4.

Sun RQ, Cai RJ, Chen YQ, Liang PS, Chen DK, Song CX. Outbreak of Porcine epidemic diarrhea in suckling piglets, China. Emerg Infect Dis. 2012; 18: 161–163. https://doi.org/10.3201/eid1801.111259

PMID: 22261231 5.

Lee S, Lee C. Outbreak-related Porcine epidemic diarrhea virus strains similar to US strains, South

Korea, 2013. Emerg Infect Dis. 2014; 20: 1223–1226. https://doi.org/10.3201/eid2007.140294 PMID:

24960370 Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 22 / 25 6.

Oh J, Lee KW, Choi HW, Lee C. Immunogenicity and protective efficacy of recombinant S1 domain of the Porcine epidemic diarrhea virus spike protein. Arch Virol. 2014; 159: 2977–2987. https://doi.org/10.

1007/s00705-014-2163-7 PMID: 25008896 7.

Jung K, Wang Q, Scheuer KA, Lu Z, Zhang Y, Saif LJ. Pathology of US Porcine epidemic diarrhea virus strain PC21A in gnotobiotic pigs. Emerg Infect Dis. 2014; 20: 662–665. https://doi.org/10.3201/eid2004.

131685 PMID: 24795932 8.

Lin CN, Chung WB, Chang SW, Wen CC, Liu H, Chien CH, et al. US-like strain of Porcine epidemic diar- rhea virus outbreaks in Taiwan, 2013–2014. J Vet Diagn Invest. 2014; 76: 1297–1299.

9.

Kocherhans R, Bridgen A, Ackermann M, Tobler K. Completion of the Porcine epidemic diarrhoea coro- navirus (PEDV) genome sequence. Virus Genes. 2001; 23: 137–144. PMID: 11724265

10.

Song D, Moon H, Kang B. Porcine epidemic diarrhea: a review of current epidemiology and available vaccines. Clin Exp Vaccine Res. 2015; 4:166–176. https://doi.org/10.7774/cevr.2015.4.2.166 PMID:

26273575 11.

Sun R, Leng Z, Zhai S-L, Chen D, Song C. Genetic variability and phylogeny of current Chinese Porcine epidemic diarrhea virus strains based on spike, ORF3, and membranegenes. Sci World J. 2014; 2014:

208439.

12.

Schwegmann-Weßels C, Herrler G. Sialic acids as receptor determinants for coronaviruses. Glycoconj

J. 2006; 23: 51–58. https://doi.org/10.1007/s10719-006-5437-9 PMID: 16575522

13.

Li BX, Ge JW, Li YJ. Porcine aminopeptidase N is a functional receptor for the PEDV coronavirus. Virol- ogy. 2007; 365: 166–172. https://doi.org/10.1016/j.virol.2007.03.031 PMID: 17467767

14.

Cong Y, Li X, Bai Y, Lv X, Herrler G, Enjuanes L, et al. Porcine aminopeptidase N mediated polarized infection by Porcine epidemic diarrhea virus in target cells. Virology. 2015; 478: 1–8. https://doi.org/10.

1016/j.virol.2015.01.020 PMID: 25681796 15.

Deng F, Ye G, Liu Q, Navid M, Zhong X, Li Y, et al. Identification and comparison of receptor binding characteristics of the spike protein of two Porcine epidemic diarrhea virus strains. Viruses. 2016; 8: 55. https://doi.org/10.3390/v8030055 PMID: 26907329

16.

Schultze B, Krempl C, Ballesteros ML, Shaw L, Schauer R, Enjuanes L, et al. Transmissible gastroen- teritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneura- minic acid) binding activity. J Virol. 1996; 70: 5634–5637. PMID: 8764078

17.

Varki A. Multiple changes in sialic acid biology during human evolution. Glycoconj J. 2009; 26: 231–

245. https://doi.org/10.1007/s10719-008-9183-z PMID: 18777136

18.

Varki A, Gagneux P. Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci. 2012; 1253: 16–

36. https://doi.org/10.1111/j.1749-6632.2012.06517.x PMID: 22524423

19.

Hayakawa T, Aki I, Varki A, Satta Y, Takahata N. Fixation of the human-specific CMP-N-acetylneurami- nic acid hydroxylase pseudogene and implications of haplotype diversity for human evolution. Genetics.

2006; 172: 1139–1146. https://doi.org/10.1534/genetics.105.046995 PMID: 16272417

20.

Moehle EA, Rock JM, Lee YL, Jouvenot Y, DeKelver RC, Gregory PD, et al. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci

U S A. 2007; 104: 3055–3060. https://doi.org/10.1073/pnas.0611478104 PMID: 17360608

21.

Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, Hummel A, et al. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics. 2010; 186: 757–761. https://doi.org/10.1534/genetics.

110.120717 PMID: 20660643 22.

Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR/

Cas systems. Science. 2013; 339: 819–823. https://doi.org/10.1126/science.1231143 PMID: 23287718

23.

Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, et al. High-frequency off-target mutagene- sis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol. 2013; 31: 822–826. https://doi. org/10.1038/nbt.2623 PMID: 23792628

24.

Shen B, Zhang W, Zhang J, Zhou J, Wang J, Chen L, et al. Efficient genome modification by CRISPR- Cas9 nickase with minimal off-target effects. Nat Methods. 2014; 11: 399–402. https://doi.org/10.1038/ nmeth.2857 PMID: 24584192

25.

Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell. 2013; 153:

910–918. https://doi.org/10.1016/j.cell.2013.04.025 PMID: 23643243

26.

Chuang Ck, Chen CH, Su YS, Peng SH, Lin TY, Huang CL, et al. Generation of GGTA1 knockout pigs by using direct pronuclear microinjection with TALEN plasmid DNA vectors. J Chin Anim Sci. 2016; 45:

223–240. (https://www.csas.org.tw/online.php?page=2)

27.

Chuang CK, Chen CH, Huang CL, Su YH, Peng SH, Lin TY, et al. Generation of GGTA1 mutant pigs by direct pronuclear microinjection of CRISPR/Cas9 plasmid vectors. Anim Biotechnol. 2017; 28: 174–

181. https://doi.org/10.1080/10495398.2016.1246453 PMID: 27834588

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 23 / 25 28.

Chuang CK, Tu CF, Chen CH. Generation of mutant pigs by direct pronuclear microinjection of

CRISPR/Cas9 plasmid vectors. Bio Protocol. 2017; 7. https://doi.org/10.21769/bioprotoc.2321

29.

National Research Council. Nutrient requirements of swine. 11th ed. Washington, D.C., USA.: National

Academic Science Press, Engineering and Medicine; 2012.

30.

Su YH, Lin TY, Huang CL, Tu CF, Chuang CK. Construction of a CRISPR-Cas9 system for pig genome targeting. Anim Biotechnol. 2015; 26: 279–288. https://doi.org/10.1080/10495398.2015.1027774

PMID: 26158460 31.

Chen C. How to control PEDV in Taiwan. 2017; https://www.angrin.tlri.gov.tw/pig/meeting/2017MET/ summary/2017PIC_4-3.pdf

32.

Thomas JT, Chen Q, Gauger PC, Gime´nez-Lirola LG, Sinha A, Harmon KM, et al. Effect of Porcine epi- demic diarrhea virus infectious doses on infection outcomes in naïve conventional neonatal and weaned pigs. PLoS One. 2015; 10: e0139266. https://doi.org/10.1371/journal.pone.0139266 PMID: 26441071

33.

Ju XD, Xu J, Sun ZS. CRISPR Editing in Biological and Biomedical Investigation. J Cell Biochem. 2018;

19:52–61.

34.

Burkard C, Lillico SG, Reid E, Jackson B, Mileham AJ, Ait-Ali T, et al. Precision engineering for PRRSV resistance in pigs: macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function. PLoS Pathog. 2017; 13: e1006206. https://doi.org/10.1371/journal.ppat.1006206 PMID: 28231264

35.

Burkard C, Opriessnig T, Mileham AJ, Stadejek T, Ait-Ali T, Lillico SG, et al. Pigs lacking the scavenger receptor cysteine-rich domain 5 of CD163 are resistant to porcine reproductive and respiratory syn- drome virus 1 infection. J Virol. 2018; 92. https://doi.org/10.1128/jvi.00415-18 PMID: 29925651

36.

Whitworth KM, Rowland RRR, Ewen CL, Trible BR, Kerrigan MA, Cino-Ozuna AG, et al. Gene-edited pigs are protected from porcine reproductive and respiratory syndrome virus. Nat Biotechnol. 2016; 34:

20–22. https://doi.org/10.1038/nbt.3434 PMID: 26641533

37.

Yang H, Zhang J, Zhang X, Shi J, Pan Y, Zhou R, et al. CD163 knockout pigs are fully resistant to highly pathogenic porcine reproductive and respiratory syndrome virus. Antiviral Res. 2018; 151: 63–70. https://doi.org/10.1016/j.antiviral.2018.01.004 PMID: 29337166

38.

Prather RS, Rowland RRR, Ewen C, Trible B, Kerrigan M, Bawa B, et al. An intact sialoadhesin (Sn/

SIGLEC1/CD169) is not required for attachment/internalization of the porcine reproductive and respira- tory syndrome virus. J Virol. 2013; 87: 9538–9546. https://doi.org/10.1128/JVI.00177-13 PMID:

23785195 39.

Popescu L, Gaudreault NN, Whitworth KM, Murgia MV, Nietfeld JC, Mileham A, et al. Genetically edited pigs lacking CD163 show no resistance following infection with the African swine fever virus isolate,

Georgia 2007/1. Virology. 2017; 501: 102–106. https://doi.org/10.1016/j.virol.2016.11.012 PMID:

27898335 40.

Kamau AN, Park JE, Park ES, Yu JE, Rho J, Shin HJ. Porcine amino peptidase N domain VII has critical role in binding and entry of porcine epidemic diarrhea virus. Virus Res. 2017; 227:150–157. https://doi. org/10.1016/j.virusres.2016.10.004 PMID: 27732876

41.

Whitworth KM, Rowland RRR, Petrovan V, Sheahan M, Cino-Ozuna AG, Fang Y, Hesse R, Mileham A,

Samuel MS, Wells KD, Prather RS. Resistance to coronavirus infection in amino peptidase N-deficient pigs. Transgenic Res. 2018; https://doi.org/10.1007/s11248-018-0100-3 PMID: 30315482

42.

Herna´ez B, Guerra M, Salas ML, Andre´s G. African swine fever virus undergoes outer envelope disrup- tion, capsid disassembly and inner envelope fusion before core release from multivesicular endosomes.

PLoS Pathog. 2016; 12: e1005595. https://doi.org/10.1371/journal.ppat.1005595 PMID: 27110717

43.

Liu C, Tang J, Ma Y, Liang X, Yang Y, Peng G, et al. Receptor usage and cell entry of Porcine epidemic diarrhea coronavirus. J Virol. 2015; 89: 6121–6125. https://doi.org/10.1128/JVI.00430-15 PMID:

25787280 44.

Chen Q, Li G, Stasko J, Thomas JT, Stensland WR, Pillatzki AE, et al. Isolation and characterization of

Porcine epidemic diarrhea viruses associated with the 2013 disease outbreak among swine in the

United States. J Clin Microbiol. 2014; 52: 234–243. https://doi.org/10.1128/JCM.02820-13 PMID:

24197882 45.

Stevenson GW, Hoang H, Schwartz KJ, Burrough ER, Sun D, Madson D, et al. Emergence of Porcine epidemic diarrhea virus in the United States: clinical signs, lesions, and viral genomic sequences. J Vet

Diagn Invest. 2013; 25: 649–654. https://doi.org/10.1177/1040638713501675 PMID: 23963154

46.

Madson DM, Magstadt DR, Arruda PHE, Hoang H, Sun D, Bower LP, et al. Pathogenesis of Porcine epidemic diarrhea virus isolate (US/Iowa/18984/2013) in 3-week-old weaned pigs. Vet Microbiol. 2014;

174: 60–68. https://doi.org/10.1016/j.vetmic.2014.09.002 PMID: 25278366

47.

Madson DM, Arruda PHE, Magstadt DR, Burrough ER, Hoang H, Sun D, et al. Characterization of Por- cine epidemic diarrhea virus Isolate US/Iowa/18984/2013 infection in 1-day-old cesarean-derived

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 24 / 25 colostrum-deprived piglets. Vet Pathol. 2016; 53: 44–52. https://doi.org/10.1177/0300985815591080

PMID: 26113613 48.

Annamalai T, Saif LJ, Lu Z, Jung K. Age-dependent variation in innate immune responses to Porcine epidemic diarrhea virus infection in suckling versus weaned pigs. Vet Immunol Immunopathol. 2015;

168: 193–202. https://doi.org/10.1016/j.vetimm.2015.09.006 PMID: 26433606

49.

Rhoads JM, MacLeod RJ, Hamilton JR. Alanine enhances jejunal sodium absorption in the presence of glucose studies in piglet viral diarrhea. Pediatr Res. 1986; 20: 879–883. https://doi.org/10.1203/

00006450-198609000-00015 PMID: 3018659 50.

Wang XY, Zhao TQ, Xu DP, Zhang X, Ji CJ, Zhang DL. The influence of porcine epidemic diarrhea virus on pig small intestine mucosal epithelial cell function. Arch Virol. 2018; https://doi.org/10.1007/ s00705-018-4061-x PMID: 30284628

51.

Cooper DKC, Ekser B, Ramsoondar J, Phelps C, Ayares D. The role of genetically engineered pigs in xenotransplantation research. J Pathol. 2016; 238: 288–299. https://doi.org/10.1002/path.4635 PMID:

26365762 52.

Alisson-Silva F, Kawanishi K, Varki A. Human risk of diseases associated with red meat intake: analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acid. Mol

Aspects Med. 2016; 51: 16–30. https://doi.org/10.1016/j.mam.2016.07.002 PMID: 27421909

Gene-edited CMAH mutant piglets display decreased porcine epidemic diarrhoea susceptibility

PLOS ONE | https://doi.org/10.1371/journal.pone.0217236

May 29, 2019 25 / 25

📖 中文全文 Chinese Full Text

中文

# 研究论文

利用CRISPR/Cas9编辑CMP-N-羟乙酰神经氨酸羟化酶基因以消除N-羟乙酰神经氨酸表达,降低仔猪对猪流行性腹泻病毒的易感性

涂清富ID1*、庄锦楷1☯、萧恺轩1,2☯、陈建华1☯¤a、陈启铭3¤b、彭素慧1、苏郁修1、邱明堂4、颜宗和1、洪绍文5、杨天树1,6、陈全木2,7

1 农业技术研究院动物技术研究所动物技术组,台湾省新竹市香山区,中华民国 2 国立中兴大学生命科学系,台湾省台中市南区,中华民国 3 农业技术研究院动物技术研究所动物医学组,台湾省新竹市香山区,中华民国 4 国立屏东科技大学兽医学院兽医学系,台湾省屏东县,中华民国 5 农业技术研究院动物技术研究所动物产业组,台湾省新竹市香山区,中华民国 6 国立宜兰大学生物技术与动物科学系,台湾省宜兰县宜兰市,中华民国 7 国立中兴大学iEGG与动物生物技术中心,台湾省台中市,中华民国

☯ 这些作者对本研究做出了同等贡献。 ¤a 现址:台湾省台中市李妇产医院生殖医学中心,中华民国 ¤b 现址:台湾省台北市昭坤生技有限公司,中华民国

* cftu@mail.atri.org.tw

## 摘要

猪流行性腹泻病毒(PEDV)严重危害仔猪健康,但利用CRISPR/Cas9基因编辑技术使CMP-N-羟乙酰神经氨酸羟化酶(CMAH)基因突变(敲除,KO)的仔猪可能不会感染PEDV。本研究通过用PEDV攻毒KO仔猪来验证这一假设。将靶向CMAH基因的两条单导RNA和Cas9 mRNA显微注射入新受精卵的胞质中。共获得4只存活的创始猪,经鉴定为双等位基因KO,体内检测不到N-羟乙酰神经氨酸(NGNA)。将创始猪进行繁育,获得纯合子后代。在实验I(n=6)和实验III(n=15)中使用2日龄仔猪,在实验II(n=9)中使用3日龄仔猪,分别将KO仔猪和相应日龄的野生型(WT)仔猪经口接种1×10³ TCID₅₀的PEDV,随后每4小时饲喂20 mL婴儿配方奶粉(实验I和实验II)或母猪初乳(实验III)。在实验III中,初乳共饲喂6次后更换为林格氏液/5%葡萄糖溶液。在PEDV接种后72小时(hpi),对死亡或安乐死的动物进行尸检并采集肠道样本。在全部3个实验中,仔猪均表现出明显的外部临床症状,提示尽管CMAH基因被敲除,感染仍然发生。在实验I中,6只WT仔猪全部在72 hpi时死亡,而6只KO仔猪中仅1只死亡。组织病理学和免疫荧光染色显示,WT仔猪的绒毛上皮细胞严重脱落,而KO仔猪仅出现中度脱落和肠细胞空泡化。在实验II中,临床症状出现延迟,但两组的免疫荧光染色/组织病理学检查(I/H)评分差异不大。在实验III中,动物在接种后表现出与实验II相似的临床和病理征象。这些结果表明,CMAH基因敲除且NGNA表达缺失的猪对PEDV并非完全免疫,但该敲除可能减轻感染的严重程度并延缓其发生。

## 引言

猪流行性腹泻(PED)最早于1971年由英国兽医Oldham认定为一种肠道疾病[1];随后,Pensaert和de Bouck[2]在比利时根特大学分离到了PED病毒(PEDV)。此后,与PEDV相关的腹泻在欧洲被广泛检出。在亚洲,该病于1982年被报道[3],此后对亚洲养猪业造成了巨大影响。2010年至2011年间,中国因PEDV相关腹泻损失了超过一百万头哺乳仔猪[4];2013年,PEDV在韩国和美国[5-7]以及台湾[8]暴发,造成了巨大的经济损失,并持续呈蔓延流行态势。

PEDV和传染性胃肠炎病毒(TGEV)同属冠状病毒科α冠状病毒属。PEDV基因组由约28 kb的正链单链RNA组成,包含7个开放阅读框(ORF),包括ORF1a、ORF1b和ORF2-6[9]。病毒颗粒表面包被有S蛋白(I型膜蛋白)。该蛋白在病毒表面形成刺突,用于感染宿主细胞,同时携带高度抗原性结构域,理论上可用于开发高效价PEDV中和疫苗[6, 10]。然而,Sun等[11]发现该区域的序列高度可变,这一特征可能降低传统商品疫苗的效力。此外,S蛋白是一种糖蛋白,经历复杂的翻译后修饰,导致抗原多样性,给PEDV疫苗的开发带来障碍[10]。

PEDV的感染途径主要通过S蛋白介导。PEDV首先与宿主肠道中的唾液酸(神经氨酸,NA)接触[12],然后通过与上皮细胞上的氨基肽酶N(APN)结合而感染肠绒毛[13, 14]。这些发现表明,NA是PEDV感染宿主肠道过程中的第一个糖蛋白受体,APN是第二个受体[15]。TGEV的感染过程与此类似[12];另一方面,猪呼吸道冠状病毒(PRCV)由于S蛋白基因组区域的突变和缺失而丧失了感染宿主肠道的能力[16]。由于S蛋白的病毒基因组序列通常具有变异性和不稳定性,但在哺乳动物(如猪)中,其受体密码子序列更为稳定,可通过基因编辑(GE)技术进行特异性操作。如上所述,PEDV通过NA和APN感染宿主,而NA已被证明在宿主免疫功能和病原体感染中发挥重要作用[17, 18]。人类细胞合成N-乙酰神经氨酸(NANA)但不合成N-羟乙酰神经氨酸(NGNA),这是因为CMP-N-羟乙酰神经氨酸羟化酶(CMAH)将NANA乙酰基中的氧插入转化为NGNA的羟乙酰基[19],而人类CMAH基因在250万至300万年的进化过程中发生了突变[17]。我们认为,类似于人类进化过程中消除PEDV的NGNA受体的方式,家猪的CMAH基因可通过基因编辑技术进行人工突变,从而产生对PEDV感染的抗性。由于APN基因对二肽消化和氨基酸吸收至关重要,因此不将其作为靶点。

目前可用的基因编辑(GE)技术包括锌指核酸酶(ZFN)[20]、转录激活因子样效应物核酸酶(TALEN)[21]和成簇规律间隔短回文重复序列(CRISPR)/CRISPR相关蛋白9(Cas9)[22]。由于载体构建和编辑技术操作便捷,且Cas9是一种通用酶,可与引导/靶向导体分开构建,因此目前CRISPR/Cas9系统在GE中的应用比ZFN和TALEN系统更为广泛。此外,GE可利用相同的Cas9同时对多个位点或基因进行操作,以实现不同的靶向目的或降低脱靶风险[23-25]。我们已建立了TALEN[26]和CRISPR/Cas9[27, 28]系统,通过直接显微注射GE载体生成α1,3-半乳糖基转移酶(GGTA1)突变猪。在本研究中,将两条单导RNA和Cas9 mRNA载体直接显微注射入猪原核期胚胎的胞质中,以生成NGNA表达缺失的CMAH突变猪,并检验获得对PEDV感染具有抗性的突变仔猪的可能性。

## 材料与方法

### 动物与动物护理

本研究使用体重至少120至150 kg的大白猪成熟小母猪或母猪及其新生仔猪。所有动物均在无特定病原体(萎缩性鼻炎、猪肺炎支原体、伪狂犬病、胸膜肺炎放线杆菌、猪痢疾、疥螨、古典猪瘟、口蹄疫和猪繁殖与呼吸综合征)的饲养站中饲养。小母猪或母猪饲养在室内混凝牛地面上,人工照明(每天9小时,450-600勒克斯),并可接受窗户自然光照。动物饲喂限制性(体重4%)商品日粮,该日粮配方满足美国国家研究委员会推荐的需求[29],并可自由饮水。

所有动物的管理和处理均获得农业技术研究院(ATRI)的许可(IACUC104004)。动物的使用及PEDV攻毒方案(包括用于确定仔猪应被安乐死的具体标准)经ATRI实验动物伦理委员会(IACUC105063)和国立屏东科技大学(NPUST)(NPUST-105-060)的批准。所有参与本研究的人员均持有猪护理或操作实验动物课程的证书。共进行了三项体内PEDV攻毒实验,总计使用60头仔猪。在为期3天的实验中,研究人员每4小时监测一次所有动物的健康和行为,兽医每天监测一次。部分仔猪(实验I中1只KO和3只WT;实验II中9只KO和7只WT;实验III中攻毒前1只KO和攻毒中1只KO)在达到安乐死标准前死亡(PEDV接种后72小时内)。在体内实验中,还考虑了动物福利,包括尽量减少痛苦和应激,必要时使用镇痛剂(3 mg/kg酮洛芬,肌肉注射,每日一次)。当仔猪出现异常临床行为,如跌倒和抽搐、呼吸急促或突然嗜睡时,即判定达到人道终点标准,立即通过肌肉注射5 mg/kg舒泰(法国维克公司)并实施放血安乐死。

### 供体与受体的处理

6头供体猪通过饲喂添加含0.4%烯丙孕素的Regumate(英特威/默沙东,法国)的日粮15天来同步发情周期,然后分别在78小时间隔内肌肉注射PMSG(1,750 IU)和hCG(1,500 IU)以诱导卵母细胞成熟和排卵。注射hCG后,对动物进行人工授精,并在30至36小时或54至56小时后实施安乐死,从输卵管中采集受精卵。3头受体猪采用与供体相同的方法同步和诱导排卵,但所有处理延迟12小时,PMSG和hCG的剂量分别减少至1,500 IU和1,250 IU,且不进行人工授精。当受精卵运抵附近实验室后,将CRISPR/Cas9 RNA显微注射入胞质中,然后在3至4小时内通过手术将卵子从输卵管伞端移植至受体的输卵管中。受体猪正常饲养,但在分娩期间给予特殊护理。

### 猪胚胎操作与显微注射

将回收的新受精卵在25°C下以15,000×g离心10至15分钟,以暴露其原核。将原核期胚胎置于载玻片腔室中20 μL的D-PBS微滴中,并用矿物油覆盖。在倒置微分干涉差(DIC)显微镜下以200至300倍放大倍数进行操作。将每个胚胎固定在适当位置以暴露原核,然后使用毛细管针将靶向两个位点的单导RNA(sgRNA,各10 ng/μL)和Cas9 RNA(70 ng/μL)的混合物显微注射入原核附近的胞质中,保持稳定流速。

### 动物繁育

经确认的CMAH KO猪(创始猪)按照SPF(无特定病原)种猪群的饲养管理规程进行饲养。当达到青春期并出现第二个发情周期后,通过饲喂Regumate并停喂来同步发情。随后,用雄性同窝创始猪采集的新鲜稀释精液对雌性创始猪进行人工授精,以产生用于研究的纯合子后代。

### CMAH基因特异性sgRNA敲除载体和Cas9载体的构建

猪CMAH基因的编码区包含14个外显子;外显子1包含8 bp,外显子2长204 bp,是最大的外显子(图1,黄色阴影的大写字母)。在验证CMAH基因外显子2和内含子1、2的序列后,我们选择了两个GN19NGG Cas9特异性序列;其中一个在正义链上有一个位点位于外显子2,另一个在反义链上有一个位点位于内含子2(图1,红色下划线字符)。根据所选位点的序列,将两对合成DNA引物(见表1)退火形成双链DNA片段,用BsalI消化后克隆至ppU6-(BsaI)2-sgRNA载体[30]中;由此构建了两种sgRNA,即ppU6-(CMAH ex2)-sgRNA和ppU6-(CMAH in2)-sgRNA。pCX-Flag2-NLS1-Cas9-NL-S2载体中的Cas9由Su等[30]构建。为使RNA可用于基因编辑,构建了pT7-Flag2-NLS1-Cas9-NLS2-3'pA、pSP6-(CMAH ex2)-sgRNA和pSP6-(CMAH in2)-sgRNA用于体外转录(S1图)。为制备加帽和加poly-A尾的Cas9 mRNA,用HindIII线性化的pT7-Flag2-NLS1-Cas9-NL-S2-3'pA DNA模板通过mMESSAGE mMACHINE T7转录试剂盒(Ambion,AM1344,美国加利福尼亚州卡尔斯巴德)进行转录。为制备CMAH单导RNA,用BglII线性化的pSP6-(CMAH ex2)-sgRNA和pSP6-(CMAH in2)-sgRNA DNA模板通过MEGAscript SP6试剂盒(Ambion,AM1330,美国加利福尼亚州卡尔斯巴德)进行转录。所有转录产物进一步通过MEGAclear转录纯化试剂盒(Ambion,AM1908,美国加利福尼亚州卡尔斯巴德)纯化后用于显微注射。

### CMAH基因突变猪的筛选

从仔猪尾部组织中提取所有由代孕母猪或创始猪分娩的猪的基因组DNA,使用基因组DNA纯化试剂盒(Fermentas/Thermo)进行纯化。CMAH突变猪首先使用0.1 μg基因组DNA和0.25 μM的CMAH Ex2 F(TGGAGCTGTCAATGCTCAGG)和CMAH Ex2 R(TCAGAGAGCTGCCGTAAAGG)引物(图1)在55°C退火条件下进行PCR筛选。野生型或位点突变猪产生约439 bp的扩增子,而同时发生双等位基因突变并缺失161 bp的动物产生约278 bp的扩增子。为进一步确认,所有PCR产物通过PCR产物直接测序(PDS)和PCR产物/TA克隆/测序(PTS)进行验证;后者至少挑选6个克隆进行测序。DNA引物合成和DNA测序由Mission生技有限公司(台湾台北)完成。测序数据使用BioEdit软件进行分析。

### 通过HPLC分析NGNA/NANA

将约100 mg的耳、尾和小肠样本切成小块,在MQ水中于95°C孵育30分钟。样品冷却至室温后,加入0.5 M H₂SO₄至终浓度25 mM。将混合物在80°C下孵育1小时,以从样本中释放唾液酸。离心后收集上清液,加入等体积的DMB(1,2-二氨基-4,5-亚甲基二氧基苯,Sigma-Aldrich公司)溶液(1 mL中含1.6 mg DMB、1.4 M乙酸、0.75 M 2-巯基乙醇和18 mM亚硫酸氢钠溶液),将混合物在80°C下孵育2小时以标记唾液酸。用作标准品的标记NGNA和NANA制备为1 mg/mL溶液,在相同标记条件下反应。将DMB标记的样品注入Waters™ HPLC系统(Waters 2475多波长荧光检测器、Waters 717 plus自动进样器和Waters 600控制器),使用Discovery BIO宽孔C18(5 μm,4.6×25 cm)色谱柱。分析采用甲醇:乙腈:H₂O(7:9:84)等度流动相,流速0.6 mL/min;荧光检测器设定激发波长373 nm,发射波长448 nm。(dx.doi.org/10.17504/protocols.io.zd6f29e)

### PEDV攻毒

**仔猪处理与设施。** 所有CMAH KO新生仔猪(参见结果部分)均由3头F₀雌性创始猪与雄性F₀创始猪交配分娩;因此,所有创始猪为半同胞或全同胞。所有创始猪均为双等位基因CMAH突变体,携带双等位基因161 bp缺失(D/D型)或一条等位基因缺失另一条突变(D/M型)的遗传背景。D/D型和/或D/M型仔猪按实验部分描述使用。对照仔猪为在同一农场由野生型母猪同时分娩的未经基因编辑的仔猪。

PEDV攻毒在NPUST的负压空调动物设施中进行。猪栏配备不锈钢网状地板,使粪便可落入下方的收集盘。室温设定为30°C,每栏配备两个额外电灯泡。

在从农场到攻毒设施的约4小时运输过程中,仔猪被保存在25°C的暗色容器中。到达攻毒室后,将突变型和野生型仔猪分组并置于不同猪栏中。约一小时后,所有仔猪经口接种PEDV,病毒用温饮用水复原的商品婴儿配方奶稀释。在实验I和实验II中,每栏动物可自由获取200 mL新鲜配制的婴儿配方奶和清洁自来水,每4小时更换一次。在实验III中,PEDV用KO或野生型母猪分娩后2天采集的猪奶稀释,不提供猪奶;改为提供新鲜饮用水,每4小时更换一次。其他处理按实验设计III描述进行。

**实验设计。** 实验I:2日龄新生仔猪的nv-PEDV攻毒。共使用6只D/D型仔猪和6只野生型仔猪进行PEDV攻毒,1只D/D型和1只野生型仔猪不经病毒处理作为对照;后者不与感染仔猪同栏饲养。所有新生仔猪哺乳约20小时以摄入初乳,然后运送至负压空调设施。

实验II:3日龄新生仔猪的nv-PEDV攻毒。本试验使用8只D/D型和1只D/M型突变仔猪以及9只野生型仔猪进行PEDV攻毒,1只D/D型突变仔猪和1只野生型仔猪不经病毒处理作为对照。所有新生仔猪哺乳约44小时以摄入初乳和母猪奶。PEDV攻毒的详细条件与实验I相同。

实验III:2日龄新生仔猪nv-PEDV攻毒后延长饲喂母猪初乳。本试验使用8只D/D型和3只D/M型突变仔猪以及12只野生型仔猪进行PEDV攻毒,1只D/D型仔猪和1只野生型仔猪不经病毒处理作为对照。所有新生仔猪哺乳约20小时以摄入初乳,然后运送至负压空调设施。在本试验中,仔猪按实验I和实验II的方式经口接种PEDV,不饲喂商品婴儿奶粉,而是饲喂在20小时内采集的母猪或其他创始猪的奶。从PEDV接种后4至24小时(hpi),每4小时手工饲喂20 mL猪奶;在4和8 hpi饲喂全奶,12至24 hpi饲喂脱脂奶。从24 hpi至72 hpi,每4小时向每头仔猪饲喂20 mL添加5%葡萄糖的乳酸林格氏液。仔猪被随机分配在24 hpi(3头)、48 hpi(3头)或72 hpi(6头)处死,并采集小肠样本。

**用于PEDV攻毒的新变异株PEDV的制备。** 新变异株PEDV(nv-PEDV)于2015年2月从台湾云林县集美农场的一个田间病例中分离获得。几乎所有受影响的一周龄仔猪均死于水样腹泻。该病的病原学确认为一株强毒力PEDV毒株(此后命名为集美毒株);该毒株的序列与2014年在美国引起PEDV暴发的毒株几乎完全相同[31]。尽管nv-PEDV可在Vero细胞系中复制,但攻毒中使用的nv-PEDV是通过经口接种未摄入初乳的新生仔猪来制备的,以保持其致病性。仔猪在温暖的隔离室中饲养,每6小时手工饲喂新鲜奶。在接种病毒后16-20小时开始出现腹泻。在观察到腹泻症状后16-24小时对仔猪实施安乐死。通过向肠腔注入50 mL添加10倍P/S的DMEM,然后从一端到另一端按摩和挤压来收集小肠内容物。将肠内容物通过不锈钢网过滤以澄清。最后,将样品以3,000×g离心以沉淀所有细胞碎片,收集上清液并分装至无菌离心管中,每管5 mL。取三小段肠道进行石蜡包埋组织切片和免疫组化(IHC)以确认PEDV存在于肠上皮细胞中(同时进行了TGEV和轮状病毒检测,结果均为阴性)。根据标准病毒学方法[32]使用TCID₅₀测定攻毒研究中使用的集美PEDV病毒制剂的病毒含量。病毒在-80°C下保存直至进行攻毒研究。按Jung等[7]描述的方法对动物进行PEDV接种。简言之,将10³ TCID₅₀/mL的冷冻nv-PEDV原液在室温下解冻,取10 mL解冻的原液与90 mL复原的商品婴儿奶或猪奶混合,反复颠倒容器。CMAH突变型和野生型仔猪经口接种10³ TCID₅₀/10 mL PEDV,使用注射器手工灌服。

**临床观察。** 接种PEDV后,每4小时观察和记录仔猪的行为,包括呕吐、腹泻和嗜睡,持续3天。当仔猪死亡或在实验结束时,记录其体重,并于当天进行尸检。

**采样。** 在空肠上段和中段以及回肠上段,通过切除约10 cm长的肠段采集所有仔猪的肠道。然后用手术线将这段肠两端结扎,剪下,向肠腔内注入适量10%福尔马林。然后将整个样品浸入约15 mL 10%福尔马林中固定至少24小时。

### 苏木精-伊红(H/E)和免疫荧光(IF)染色

固定后,将仔猪肠道样本切片、石包埋并切成3至4 μm厚度的切片。将切片置于载玻片上,在二甲苯中脱蜡,依次用100%、95%、80%和70%乙醇处理,然后用H/E染色。对于IF染色,将切片在二甲苯和100%乙醇中脱蜡,然后在沸腾的TAE缓冲液中加热3分钟以激活抗原。冷却至室温后,用PBS洗涤载玻片15分钟,用针对PEDV的一抗(由陈启铭博士制备)和商品化二抗FITC偶联的山羊抗小鼠免疫球蛋白(Cappel)对组织进行染色。浸入DAPI溶液后,用10%甘油封片,在Olympus BX50显微镜(日本奥林巴斯)下用紫外光观察信号。

### 病理学评估

用于对PEDV相关免疫荧光(IF)染色和组织病理学病变(I/H评分)进行评分的标准如图2所示。PEDV主要感染形成小肠黏膜的上皮细胞。在小肠的三个不同位置评估每个部位,其平均值代表一头仔猪的数据。在PEDV感染的早期阶段,只有IF染色能让我们观察上皮细胞是否被PEDV感染。因此,在该阶段,IF阳性细胞的百分比是判断PEDV感染严重程度的唯一标准。然而,在感染的中晚期,PEDV感染的严重程度最好通过绒毛萎缩程度来判断,因为受感染的细胞经常从黏膜上脱落,IF可能无法显示PEDV感染的细胞。因此,病变评分从1到5,如图2C所示;评分结合了IF染色和组织病理学检查的结果,形成I/H评分,用于最终统计分析。

### 统计分析

所有临床和存活数据均使用GraphPad Prism 6(GraphPad软件公司)记录和分析。仔猪在PEDV攻毒后的存活率(曲线)使用Log-rank(Mantel-Cox)和Gehan-Breslow-Wilcoxon检验进行分析。t-test用于分析从所有实验仔猪肠道样本中获得的体重和免疫/组织病理学数据。显著性水平(α)设定为0.05。

## 结果

### CMAH突变猪的生成

共70个受精卵(表2)被显微注射了CRISPR RNA,包括靶向CMAH基因外显子2和内含子2上两个位点的两条sgRNA(图1),以及Cas9 mRNA,并移植至3头代孕母猪。一头妊娠母猪产下5只活仔猪和1只死产仔猪(表2)。CMAH KO的PCR分析显示,1只雄性(L667-02)和3只雌性(L667-10、-11和-12)(图3A)携带161 bp缺失突变(图3B)。通过PCR直接测序(PDS)和PCR产物在T-A克隆载体中的亚克隆和测序(PTS)进一步分析显示,4只活仔猪和死产仔猪均为双等位基因CMAH突变体;其中L667-02为双等位基因161 bp缺失(D/D型)(图4A),L667-10、-11和-12为D/D型与两个位点突变(D/D和D/M型)的嵌合体(图4A-4C),死产仔猪(L667-D)在位点I有一个单碱基突变和5 bp插入,在位点II有一个5 bp缺失(M/M型)(图4B和4C)。基于操作胚胎数量的基因编辑和KO效率为7.5%,基于分娩仔猪数量的效率为83.3%,所有仔猪均为双等位基因突变体(表2)。

用于PEDV攻毒的动物是通过将三头创始母猪(L667-10、11和12)与创始公猪(L667-02)交配获得的。其后代的突变状态(表3)通过PCR、PDS和PTS确认(S2-S4图)。所有仔猪均通过PCR快速筛选,优先使用D/D型仔猪进行实验。在实验II和实验III中,D/D型仔猪分别补充了1只和3只D/M型仔猪(表4),经PTS确认其在突变染色体位点I上有1 bp插入或14 bp或2 bp缺失(S2-S4图)。基于HPLC检测NGNA/NANA对CMAH基因表达缺失的分析显示,所有创始猪(图5)及其后代(S5图)均缺乏NGNA表达。这些结果表明,所有创始猪及其后代均为双等位基因突变体,不能表达CMAH,其组织中不产生NGNA。

### nv-PEDV攻毒新生仔猪的临床观察

**实验I:** 当2日龄新生仔猪用nv-PEDV攻毒时,CMAH突变型(敲除,KO)和野生型(WT)动物均在接种后12小时(hpi)最初表现出呕吐和腹泻的临床症状,活动力也下降(表5)。在WT组中,第一头仔猪死亡发生在44 hpi;第二头在52 hpi死亡,第三头在68 hpi死亡,其余三头在72 hpi时处于濒死状态(图6A)。在CMAH KO组中,第一头仔猪在60 hpi死亡,3头在72 hpi时处于濒死状态,其余两头仔猪存活至试验结束(图6A和表5)。nv-PEDV接种后,WT仔猪的体重下降为0.69±0.04 kg,显著(p<0.01)大于CMAH KO仔猪的体重下降(0.45±0.03 kg)(图7A)。

**实验II:** 按实验I的方法检查3日龄仔猪。尽管CMAH KO和WT动物均在12 hpi最初表现出呕吐和腹泻的临床症状,但2只KO和4只WT仔猪无临床症状(表5)。此外,所有仔猪的活动力维持至24 hpi(表5)。在WT组中,第一头死亡发生在40 hpi(图6B);48 hpi时损失2头,56 hpi时死亡4头,其余两头仔猪在试验结束时仍然存活。在CMAH KO组中,第一头在44 hpi死亡,分别在52、56、64和68 hpi时死亡3、3、1和1头仔猪(图6B)。两组仔猪的体重下降无显著差异(WT/-0.60±0.02 kg对比CMAH KO/-0.55±0.04 kg;p>0.05)(图7B)。

**实验III:** 为检查早期事件和NGNA在nv-PEDV感染新生仔猪中的作用,我们使用2日龄仔猪进行nv-PEDV攻毒。感染后,仔猪每4小时饲喂猪奶和脱脂奶,持续24小时;然后更换为添加5%葡萄糖的乳酸林格氏液,并在24、48和72 hpi时处死。结果(表6)显示,在12 hpi之前,CMAH KO和WT仔猪均表现正常活跃;然而,关于临床症状,11只CMAH KO仔猪中仅有3只在12 hpi时未出现腹泻或呕吐。从4至24 hpi,所有仔猪均饲喂母猪全奶或脱脂奶;结果显示,所有仔猪活动力下降并出现腹泻,CMAH KO和WT仔猪之间无显著差异。在44 hpi观察到1只濒死的CMAH KO仔猪,在56 hpi观察到1只濒死的WT仔猪;所有仔猪在24 hpi后停止呕吐。在用RLG替代猪奶后,所有仔猪(CMAH KO和WT)至少在56 hpi前维持活动力和存活率,除1只CMAH KO仔猪在试验结束前死亡外(表6)。

### nv-PEDV攻毒新生仔猪的免疫/组织病理学

在72 hpi后,对所有死亡和安乐死的仔猪进行尸检,采集肠道样本进行病理检查。肉眼观察,小肠呈透明状,颜色为橙黄色至肉粉色,肠壁变薄并扩张,存活仔猪肠腔内含有液体内容物(S6A和S6B图)。在实验I中,PEDV引起的组织病理学变化,包括肠上皮细胞坏死、变性和脱落,以及含有核碎裂碎片的固有层组织皱缩,在所有攻毒仔猪中均可见到。然而,这些病变从轻度到重度不等,濒死的WT仔猪的病变比CMAH KO仔猪更为严重(图8)。使用针对PEDV核蛋白的单克隆抗体进行免疫荧光(IF)染色以检测PEDV抗原。结果显示,PEDV抗原存在于WT和CMAH KO仔猪小肠绒毛中度萎缩顶端的上皮细胞中(图9)。然而,如果上皮细胞在PEDV感染后从绒毛上脱落,则不会出现阳性信号(图9A)。我们通过结合IF染色和组织病理学检查(免疫/组织病理学,I/H评分)进一步对感染动物肠道病变严重程度进行评分(图2)。根据I/H评分,结果显示KO仔猪(3.7±0.3至4.2±0.2)的肠道病变严重程度低于WT仔猪(4.8±0.2)(p<0.05);但在实验II中,WT仔猪(3.4±0.6至4.4±0.3)和CMAH KO仔猪(4.3±0.4至4.7±0.2)之间无显著差异(表7)。在实验III中,即使排除了饲喂商品婴儿奶粉的可能影响,我们也发现WT和CMAH KO仔猪的I/H评分无显著差异(表8)。根据72 hpi时的I/H评分,CMAH KO仔猪为3.8±0.4至3.2±0.5,WT仔猪为2.8±0.4至2.5±0.2(p>0.05),与24和48 hpi时相比,大多数仔猪似乎有所改善,当时提供了猪奶和添加5%葡萄糖的乳酸林格氏液补充(表8)。

## 讨论

目前,基因编辑广泛应用于基础和应用研究,例如家畜抗病性研究[33]。一项令人信服的报告显示,通过CRISPR/Cas9生成的CD163基因编辑猪表现出生理正常,并且在体外[34]和体内[35-37]对猪繁殖与呼吸综合征病毒(PRRSV)感染的易感性极低。然而,其他尝试,包括推定的CD169 KO和CD163 KO受体,未能产生对PRRSV[38]或非洲猪瘟[39]的明显抗性。这些失败可能是因为病毒感染机制涉及其他受体或不涉及受体[38]。

CMAH KO仔猪中NGNA表达缺失使PEDV感染失效的假说在本研究中得到了部分验证。在实验I中,2日龄仔猪经口接种本地暴发毒株nv-PEDV[31]。尽管WT和KO动物在最终(72 hpi)存活率方面差异不大,但基于组织病理学检查并考虑到3头濒死的WT仔猪,CMAH KO仔猪对nv-PEDV感染表现出比WT动物更强的抵抗力。WT仔猪中发现的严重组织病理学变化程度明显不同于CMAH KO仔猪中观察到的结果,支持了这一假设。然而,当使用3日龄仔猪时,CMAH KO和WT仔猪之间未观察到差异。牛奶奶粉配方中存在的NGNA是否会使病毒能够感染CMAH KO仔猪令人质疑。在实验III中,为避免任何可能的NGNA干扰,给予KO或WT母猪的初乳,但由于NGNA含量极少或几乎没有(S7图),两种基因型的最终易感性相似。然而,11只CMAH KO仔猪中至少有3只在12 hpi时表现出正常活动且无临床症状(无呕吐或腹泻),而WT仔猪则出现呕吐和/或腹泻。因此观察到了严重程度的减轻。

考虑到传染性胃肠炎病毒(TGEV)和其他冠状病毒使用唾液酸(神经氨酸,NA)和APN作为其第一[12,15]和第二受体[13,15],PEDV可能以类似方式发挥作用。最近,APN的结构域VII被提出在PEDV结合中发挥关键作用[40];然而,当使用CRISPR/Cas9编辑使ANPEP(APN)基因无效突变时,KO仔猪虽未感染TGEV但仍对PEDV易感[41]。我们发现猪小肠黏膜下层中黏蛋白的主要成分是两种类型的NA——N-乙酰神经氨酸(NANA)和N-羟乙酰神经氨酸(NGNA)(未发表数据)。Liu等[42]使用糖芯片筛选表明,Neu5Ac(或NANA)对PEDV S1-NTD-CTD具有最高的结合亲和力;但他们还发现,猪黏蛋白或牛黏蛋白可以抑制或阻断体外PEDV和TGEV对转染了猪APN的PK-15或Huh-7细胞的感染。本研究结果表明,CMAH KO仔猪在经口接种PEDV后表现出感染延迟和轻微症状,提示在正常哺乳的CMAH KO仔猪中,PEDV可能无法有效地与肠绒毛上皮细胞上的APN结合而通过肠腔。病毒通过受体感染可能是PRRSV[35-37]和TGEV[12,15,41]的唯一途径,但对PEDV而言并非如此,PEDV可能通过受体以外的更复杂机制感染[43]。

已知PEDV在哺乳仔猪中引起严重的肠道疾病[44,45],在较大日龄断奶猪中引起的疾病较轻[46]。我们的结果提示,这种分化可能早在新生儿期就已发生;在2日龄仔猪中观察到所有临床腹泻和/或呕吐及活动力下降,但在3日龄仔猪中有所改善。当使用剖腹产且未摄入初乳(CDCD)的动物进行PEDV经口接种时,1日龄仔猪在12 hpi时表现出临床症状[47];这在我们使用自然分娩仔猪的研究中也得到了观察。此外,在PEDV接种研究中,5日龄CDCD仔猪比21日龄断奶仔猪更为敏感[32]。同样,自然分娩的9日龄哺乳仔猪对PEDV的先天免疫反应弱于断奶猪[48]。本研究使用2或3日龄仔猪,在PEDV经口接种前由CMAH KO或WT母猪自然分娩并哺乳摄入初乳,试图实现双等位基因CMAH基因突变动物中哺乳的保护作用。在实验III中,2日龄仔猪经PEDV接种后额外24小时手工饲喂全奶或脱脂猪奶,其临床症状与实验II中的3日龄仔猪相似。此外,当在24至72 hpi提供添加5%葡萄糖的乳酸林格氏液时,绒毛上皮细胞根据I/H评分显示损伤减轻和/或隐窝上皮细胞恢复增加,WT仔猪的I/H评分范围为4.0±0.0至2.5±0.2,KO组为5.0±0.0至3.2±0.5。口服补液疗法在急性病毒性腹泻中的益处可归因于葡萄糖促进的钠吸收[49]以及减轻Na⁺-K⁺-ATPase和Ca²⁺-Mg²⁺-ATPase的损伤[50]。目前,该模型可通过接种仔猪并允许其持续由相同基因型的母猪哺乳来改进,以避免NGNA干扰。

除了抗病性外,CMAH和GGTA1 KO动物可能还表现出异种移植超急性排斥反应的减少[51]。我们未发表的数据还显示,源自CMAH KO猪肠道的无细胞细胞外基质在肌肉内植入CMAH/GGTA1双KO猪后引起的炎症显著少于从WT猪获得的基质。此外,红肉中存在的NGNA被认为是习惯性食用红肉的人群患结直肠癌和动脉粥样硬化的危险因素[52]。因此,通过GE生成的CMAH突变猪可被视为提供健康红肉和适用于生物医学设备材料来源的猪品种。

总之,通过基因编辑生成的CMAH突变猪可能成为对PEDV易感性降低的新品种,可作为医用材料和异种移植的供体来源,以及健康红肉的来源。

## 补充材料

S1图. pT7-Flag2-NLS1-Cas9-NLS2-3'pA和pSP6-CMAH-sgRNA载体的代表性图谱。T7和SP6启动子分别用于体外转录Cas9 mRNA和CMAH-sgRNA。NLS1和NLS2是核定位序列[30]。EcoRI、MluI、Acc65I、HindIII、BamHI和BglII是限制性酶切位点。Amp是氨苄青霉素抗性基因,用于载体构建过程中的质粒筛选。Flag标签用于评估Cas9蛋白表达。

S2图. 第一胎CMAH基因编辑后代的分析。A. 显示多于一条带的PCR产物进一步亚克隆至TA载体中进行菌落纯化和测序。B. 在位点I(外显子II)和位点II(内含子2)有突变的后代。C. 携带两个位点同时突变的后代,缺失161 bp DNA片段,其中一些显示额外的+1或-5 bp插入缺失。D1-D5为死产仔猪。在PCR中,+和-分别为反应阳性和阴性对照。

S3图. 第二胎CMAH基因编辑后代的分析。A. 显示多于一条带的PCR产物进一步亚克隆至TA载体中进行菌落纯化和测序。B. 在位点I(外显子II)和位点II(内含子2)有突变的后代。C. 携带两个位点同时突变的后代,缺失161 bp DNA片段,其中一些显示额外的+1或-5 bp插入缺失。

S4图. 第三胎CMAH基因编辑后代的分析。A. 显示多于一条带的PCR产物进一步亚克隆至TA载体中进行菌落纯化和测序。B. 在位点I(外显子II)和位点II(内含子2)有突变的后代。C. 携带两个位点同时突变的后代,缺失161 bp DNA片段,其中一些显示额外的+1或-5 bp插入缺失。

S5图. 六只CMAH KO创始猪F1后代耳组织中NGNA/NANA的HPLC分析。NGNA和NANA的保留时间以峰上的数字显示。

S6图. 新生仔猪在72 hpi或试验期间死亡时小肠的大体外观。A. KO0和WT0为未接种nv-PEDV的对照仔猪。B. KO1至KO5为存活的KO仔猪。

S7图. 通过HPLC分析KO和WT母猪初乳或商品婴儿奶粉中的NGNA。蓝线显示保留时间(RT)为9.51-9.52分钟的非特异性峰,出现在所有样品中。NGNA峰的RT为9.671-9.737分钟,接近非特异性峰。STD表示NGNA或NANA的标准样品。

## 致谢

作者衷心感谢徐庆云先生、许绍清先生和黄志宏先生对实验动物护理提供的帮助,特别是对KO猪的护理。还要感谢刘明兴女士在猪手术和胚胎移植方面的技术协助,以及林昭南博士在国立科技大学PEDV攻毒试验中提供的协助。

## 作者贡献

**概念化:** 涂清富、庄锦楷、杨天树、陈全木。 **数据整理:** 涂清富、萧恺轩、陈建华、陈启铭、彭素慧、苏郁修、邱明堂、颜宗和、洪绍文。 **形式分析:** 涂清富、萧恺轩、陈启铭、彭素慧、苏郁修、颜宗和、洪绍文、杨天树。 **资金获取:** 涂清富。 **调查研究:** 涂清富、庄锦楷、萧恺轩、陈建华、陈启铭、彭素慧、苏郁修、邱明堂、颜宗和、洪绍文、杨天树。 **方法学:** 涂清富、庄锦楷、萧恺轩、陈建华、陈启铭、彭素慧、苏郁修、邱明堂、颜宗和、洪绍文。 **项目管理:** 涂清富、萧恺轩。 **资源提供:** 涂清富、陈启铭、邱明堂。 **软件:** 洪绍文。 **监督:** 涂清富、陈启铭、杨天树、陈全木。 **验证:** 涂清富、庄锦楷、陈启铭、邱明堂、颜宗和、杨天树。 **可视化:** 涂清富。 **撰写——原稿:** 涂清富、萧恺轩、陈启铭、彭素慧、洪绍文、杨天树、陈全木。 **撰写——审阅与编辑:** 涂清富、陈建华、颜宗和、杨天树、陈全木。